BN/SsN |
blood glucose level |
glucose solution (2 g/kg) |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood glucose amount |
both |
118.0 days-125.0 days |
220 |
|
108.54 |
mg/dl |
1.02 |
15.12 |
|
intraperitoneal glucose tolerance test |
|
0 |
glucose injection |
0 |
min |
|
|
|
|
65945 |
114 |
F344/NRrrc |
blood glucose level |
glucose solution (2 g/kg) |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood glucose amount |
both |
118.0 days-125.0 days |
220 |
|
123.12 |
mg/dl |
0.81 |
12.06 |
|
intraperitoneal glucose tolerance test |
|
0 |
glucose injection |
0 |
min |
|
|
|
|
65948 |
114 |
F344/DuCrl |
blood glucose level |
fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) |
Galli J, et al., NatGenet 1996 Jan;12(1):31-7. |
blood glucose amount |
not specified |
65.0 days
| 10 |
|
55.8 |
mg/dl |
5.4 |
17.08 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
glucose injection |
0 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11393 |
82 |
OLETF/Got |
blood glucose level |
control condition |
Ogino GenetRes 73:29 '99 |
blood glucose amount |
male |
42.0 days
| 13 |
|
108.4 |
mg/dl |
2.2 |
7.93 |
|
blood glucose test strip read by electrochemical glucometer |
tail |
0.0 |
|
0 |
|
Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan |
converted from mg/dl |
|
|
11420 |
84 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65.0 days
| 11 |
|
309.6 |
mg/dl |
9.0 |
29.85 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
15 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11462 |
85 |
F344/DuCrlCrlj |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65.0 days
| 15 |
|
286.2 |
mg/dl |
7.2 |
27.89 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
15 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11461 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 11 |
|
127.8 |
mg/dl |
3.6 |
11.94 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11432 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 11 |
|
333.0 |
mg/dl |
14.4 |
47.76 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
15 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11442 |
85 |
GK/KyoSwe |
blood glucose level |
fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) |
Galli J, et al., NatGenet 1996 Jan;12(1):31-7. |
blood glucose amount |
not specified |
65.0 days
| 22 |
|
363.6 |
mg/dl |
12.6 |
59.1 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
glucose injection |
60 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11386 |
82 |
F344.GK-(D1Rat175-D1Rat90)/Swe |
blood glucose level |
fasting (for 6 hours) then glucose solution (2 g/kg) |
Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. |
blood glucose amount |
male |
95.0 days
| 12 |
|
396.0 |
mg/dl |
10.8 |
37.41 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
15 |
min |
|
|
|
|
13096 |
330 |
F344.GK-(D1Got250-D1Rat90)/Swe |
blood glucose level |
fasting (for 6 hours) then glucose solution (2 g/kg) |
Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. |
blood glucose amount |
male |
95.0 days
| 12 |
|
369.0 |
mg/dl |
9.0 |
31.18 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
15 |
min |
|
|
|
|
13101 |
330 |
F344.GK-(D1Swe4-D1Rat85)/Swe |
blood glucose level |
fasting (for 6 hours) then glucose solution (2 g/kg) |
Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. |
blood glucose amount |
male |
95.0 days
| 12 |
|
306.0 |
mg/dl |
9.0 |
31.18 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
15 |
min |
|
|
|
|
13114 |
330 |
F344/NSlc |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 22 |
|
106.0 |
mg/dl |
2.0 |
9.38 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
90 |
min |
Arkray, Kyoto, Japan |
|
|
|
13209 |
230 |
F344/NSlc |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 22 |
|
107.3 |
mg/dl |
2.0 |
9.38 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
120 |
min |
Arkray, Kyoto, Japan |
|
|
|
13210 |
230 |
F344.OLETF-(D14Rat8-D14Rat26)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 15 |
|
111.9 |
mg/dl |
2.5 |
9.68 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
120 |
min |
Arkray, Kyoto, Japan |
|
|
|
13220 |
230 |
F344.OLETF-(D8Rat54-D8Mgh17)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 19 |
|
119.3 |
mg/dl |
3.1 |
13.51 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
120 |
min |
Arkray, Kyoto, Japan |
|
|
|
13225 |
230 |
SHR/Mol |
blood glucose level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33. |
blood glucose amount |
not specified |
84.0 days-98.0 days |
24 |
|
102.0 |
mg/dl |
1.02 |
5.0 |
|
automated blood analysis |
opthalmic plexus |
0.0 |
|
0 |
|
mean of samples at 12, 13 and 14 weeks |
|
|
|
12932 |
323 |
SDT/Jcl |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420.0 days
| 5 |
|
705.0 |
mg/dl |
46.77 |
104.58 |
|
oral glucose tolerance test |
|
0 |
oral dose |
15 |
min |
|
|
|
|
13164 |
106 |
SDT/Jcl |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420.0 days
| 5 |
|
640.6 |
mg/dl |
16.99 |
37.99 |
|
oral glucose tolerance test |
|
0 |
oral dose |
120 |
min |
|
|
|
|
13168 |
106 |
SDT/Jcl |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420.0 days
| 5 |
|
767.2 |
mg/dl |
17.6 |
39.35 |
|
oral glucose tolerance test |
|
0 |
oral dose |
30 |
min |
|
|
|
|
13166 |
106 |
F344/NSlc |
blood glucose level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood glucose amount |
male |
211.0 days
| 7 |
|
78.0 |
mg/dl |
2.6 |
6.88 |
|
oral glucose tolerance test |
|
0 |
oral glucose |
0 |
min |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
|
|
|
12770 |
311 |
F344.OLETF-(D1Mit20-D1Mgh26)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 15 |
|
105.9 |
mg/dl |
2.0 |
7.75 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
120 |
min |
Arkray, Kyoto, Japan |
|
|
|
13235 |
230 |
F344.OLETF-(D1Rat166-D1Rat90)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 12 |
|
111.6 |
mg/dl |
2.1 |
7.27 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
90 |
min |
Arkray, Kyoto, Japan |
|
|
|
13239 |
230 |
F344.OLETF-(D12Wox5-D12Rat21)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 13 |
|
100.0 |
mg/dl |
2.3 |
8.29 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
30 |
min |
Arkray, Kyoto, Japan |
|
|
|
13252 |
230 |
F344.OLETF-(D16Wox4-D16Rat13)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 10 |
|
105.8 |
mg/dl |
2.8 |
8.85 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
60 |
min |
Arkray, Kyoto, Japan |
|
|
|
13263 |
230 |
F344.OLETF-(D14Rat8-D14Rat26)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 14 |
|
118.9 |
mg/dl |
2.2 |
8.23 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
120 |
min |
Arkray, Kyoto, Japan |
|
|
|
13260 |
230 |
F344.OLETF-(D10Wox7-D10Wox6)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 7 |
|
84.7 |
mg/dl |
1.9 |
5.03 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
0 |
min |
Arkray, Kyoto, Japan |
|
|
|
13266 |
230 |
DA/K |
blood glucose level |
glucose solution (2 g/kg) |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
blood glucose amount |
female |
0.0 days
| 12 |
|
105.0 |
mg/dl |
|
|
|
intraperitoneal glucose tolerance test |
|
0.0 |
intraperitoneal injection |
0 |
min |
glucose analyser (Medingen ESAT 6660-2, Germany) |
average of measures taken at 196 days, 210 days and 224 days |
|
|
13273 |
251 |
F344/NRrrc |
blood glucose level |
glucose solution (2 g/kg) |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood glucose amount |
both |
118.0 days-125.0 days |
220 |
|
249.12 |
mg/dl |
5.16 |
76.5 |
|
intraperitoneal glucose tolerance test |
|
0 |
glucose injection |
30 |
min |
|
|
|
|
65977 |
114 |
BB.SHR-(Gnal-D18Mit9)/K |
blood glucose level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood glucose amount |
both |
84.0 days
| 25 |
|
107.0 |
mg/dl |
2.6 |
13.0 |
|
automated blood analysis |
opthalmic venous plexus |
0.0 |
|
0 |
|
|
|
|
|
70111 |
324 |
Crl:SD |
blood glucose level |
controlled fructose content drinking water (5 %) (for 63 days) and controlled bisphenol A content drinking water (0.025 mg/l) (for 63 days) |
Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8. |
blood glucose amount |
female |
98.0 days
| 12 |
|
81.0 |
mg/dl |
2.34 |
8.1 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
week one |
|
|
75793 |
1538 |
SD |
blood glucose level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
male |
85.0 days-99.0 days |
6 |
|
62.11 |
mg/dl |
13.41 |
32.84 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
Siemens biochemical analyzer |
|
|
|
84992 |
1602 |
SD |
blood glucose level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
female |
71.0 days-85.0 days |
6 |
|
181.5 |
mg/dl |
3.6 |
8.83 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
Siemens biochemical analyzer |
|
|
|
84996 |
1602 |
SD |
blood glucose level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
male |
71.0 days-85.0 days |
6 |
|
115.3 |
mg/dl |
5.86 |
14.35 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
Siemens biochemical analyzer |
|
|
|
84987 |
1602 |
OLETF |
blood glucose level |
control condition (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
blood glucose amount |
male |
364.0 days
| 12 |
|
186.3 |
mg/dl |
6.84 |
23.69 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
99416 |
2298 |
LH/Mav |
blood glucose level |
streptozotocin (75 mg/kg) then fasting (for 16 hours) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood glucose amount |
male |
56.0 days
| 14 |
|
72.0 |
mg/dl |
1.0 |
3.74 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
102717 |
2721 |
Jcl:WI |
blood glucose level |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
blood glucose amount |
male |
84.0 days
| 8 |
|
162.36 |
mg/dl |
16.1 |
45.54 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
103071 |
2785 |
GK |
blood glucose level |
vehicle control condition (for 28 days) then fasting (for 16 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
blood glucose amount |
male |
168.0 days
| 6 |
|
122.0 |
mg/dl |
8.0 |
19.6 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103512 |
2827 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0.0 days
| 16 |
|
317.0 |
mg/dl |
19.0 |
76.0 |
|
machine read blood glucose test strip |
|
0.0 |
unx |
168 |
days |
|
|
|
|
99974 |
2378 |
GK |
blood glucose level |
sham surgical control condition (for 24 days) then fasting (for 12 hours) |
Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31. |
blood glucose amount |
female |
87.0 days
| 6 |
|
172.0 |
mg/dl |
9.0 |
22.05 |
|
machine read blood glucose test strip |
|
0.0 |
|
0 |
|
|
|
|
|
103759 |
2782 |
LH-Chr 17LN/Aek |
blood glucose level |
controlled sodium content diet (0.3 %) (for 105 days) then controlled sodium content diet (4 %) (for 21 days) |
Ma MCJ, et al., PLoS One. 2017 Aug 8;12(8):e0182650. doi: 10.1371/journal.pone.0182650. eCollection 2017. |
blood glucose amount |
male |
126.0 days
| 11 |
|
98.0 |
mg/dl |
15.3 |
50.74 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
102779 |
2722 |
GK/MolTac |
blood glucose level |
rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 16 hours) then glucose solution (2 g/kg) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood glucose amount |
male |
122.0 days-129.0 days |
4 |
|
177.0 |
mg/dl |
5.5 |
11.0 |
|
oral glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
103809 |
2864 |
Jcl:WI |
blood glucose level |
control condition then fasting (for 0 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
52.0 days
| 6 |
|
81.14 |
mg/dl |
3.51 |
8.6 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103928 |
2884 |
GK/Jcl |
blood glucose level |
control condition then fasting (for 0 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
52.0 days
| 6 |
|
130.71 |
mg/dl |
6.23 |
15.26 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103929 |
2884 |
WKY |
blood glucose level |
streptozotocin (60 mg/kg) then gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (40000000000 PFU) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
blood glucose amount |
male |
156.0 days
| 10 |
|
533.7 |
mg/dl |
25.56 |
80.83 |
|
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
|
|
99103 |
2219 |
SD |
blood glucose level |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
blood glucose amount |
male |
0.0 days
| 8 |
|
334.0 |
mg/dl |
19.8 |
56.0 |
|
blood glucose analysis |
|
0.0 |
stz |
154 |
days |
|
|
|
|
99896 |
2358 |
SD |
blood glucose level |
control condition |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
blood glucose amount |
male |
0.0 days
| 8 |
|
106.0 |
mg/dl |
4.6 |
13.0 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
99898 |
2358 |
SD |
blood glucose level |
nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) and paricalcitol (0.3 ug/kg) (for 70 days) |
Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. |
blood glucose amount |
male |
140.0 days
| 6 |
|
138.6 |
mg/dl |
10.3 |
25.23 |
|
blood glucose analysis |
|
0.0 |
unx |
84 |
days |
|
|
|
|
100124 |
2419 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0.0 days
| 7 |
|
74.0 |
mg/dl |
2.0 |
5.29 |
|
machine read blood glucose test strip |
|
0.0 |
unx |
28 |
days |
|
|
|
|
99940 |
2378 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0.0 days
| 6 |
|
367.0 |
mg/dl |
12.0 |
29.39 |
|
machine read blood glucose test strip |
|
0.0 |
unx |
28 |
days |
|
|
|
|
99944 |
2378 |
SD-Fhem1+/+ |
blood glucose level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood glucose amount |
male |
0.0 days
| 3 |
|
147.6 |
mg/dl |
3.12 |
5.4 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
|
|
|
|
104965 |
2989 |
SD-Fhem1+/+ |
blood glucose level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood glucose amount |
female |
0.0 days
| 3 |
|
115.2 |
mg/dl |
14.55 |
25.2 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
|
|
|
|
104966 |
2989 |
MNS |
blood glucose level |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 84 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
168.0 days
| 8 |
|
453.6 |
mg/dl |
15.91 |
45.0 |
|
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
|
|
104078 |
2907 |
SS/JrHsdMcwi |
blood glucose level |
fasting (for 12 hours) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
blood glucose amount |
male |
84.0 days
| 8 |
|
117.0 |
mg/dl |
2.0 |
5.66 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
105863 |
3023 |
SS-Adora2bem2Mcwi |
blood glucose level |
fasting (for 12 hours) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
blood glucose amount |
male |
140.0 days-168.0 days |
8 |
|
96.0 |
mg/dl |
2.0 |
5.66 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
105865 |
3023 |
SBH/Ygl |
blood glucose level |
controlled sodium chloride content diet (8 %) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
blood glucose amount |
male |
98.0 days
| 7 |
|
109.8 |
mg/dl |
3.6 |
9.52 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
106693 |
3038 |
SBH/Ygl |
blood glucose level |
controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
blood glucose amount |
male |
98.0 days
| 7 |
|
383.4 |
mg/dl |
21.6 |
57.15 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
106694 |
3038 |
GK |
blood glucose level |
running (3.91 km/d) (for 42 days) then fasting (for 12 hours) then glucose (1 g/kg) (for 1 hours) |
Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015. |
blood glucose amount |
male |
0.0 days
| 20 |
|
295.02 |
mg/dl |
14.58 |
65.2 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
60 |
min |
|
|
|
|
109904 |
3160 |
GK/MolTac |
blood glucose level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood glucose amount |
female |
60.0 days
| 6 |
|
268.2 |
mg/dl |
14.4 |
35.27 |
|
blood glucose test strip read by optical glucometer |
|
0.0 |
|
0 |
|
tail vein blood |
|
|
fasting blood glucose, non fasting blood glucose |
106905 |
3071 |
WKY/NMolTac |
blood glucose level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood glucose amount |
female |
60.0 days
| 6 |
|
106.2 |
mg/dl |
7.2 |
17.64 |
|
blood glucose test strip read by optical glucometer |
|
0.0 |
|
0 |
|
|
|
|
fasting blood glucose, non fasting blood glucose |
106908 |
3071 |
GK/Jpe |
blood glucose level |
controlled cholesterol content diet (1.25 %) (for 90 days) and controlled cocoa butter content diet (7.5 %) (for 90 days) then soybean oil (2 ml/kg) then fasting (for 15 hours) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
blood glucose amount |
male |
540.0 days
| 10 |
|
129.6 |
mg/dl |
4.5 |
14.23 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
108007 |
3108 |
GK/Jpe |
blood glucose level |
controlled cholesterol content diet (1.25 %) (for 90 days) and controlled cocoa butter content diet (7.5 %) (for 90 days) then fasting (for 15 hours) then glucose solution (1.75 g/kg) (for 2 hours) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
blood glucose amount |
male |
540.0 days
| 10 |
|
419.1 |
mg/dl |
28.5 |
90.12 |
|
intraperitoneal glucose tolerance test |
|
0.0 |
|
120 |
min |
|
|
|
|
108011 |
3108 |
Crlj:WI |
blood glucose level |
fasting (for 17 hours) |
Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412. |
blood glucose amount |
male |
224.0 days-238.0 days |
5 |
|
106.8 |
mg/dl |
3.8 |
8.5 |
|
automated plasma glucose analysis |
|
0.0 |
|
0 |
|
200ul blood taken from tail vein |
|
|
|
108089 |
3070 |
WKY/NMolTac |
blood glucose level |
fasting (for 6 hours) |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood glucose amount |
female |
240.0 days
| 9 |
|
84.6 |
mg/dl |
1.8 |
5.4 |
|
blood glucose test strip read by optical glucometer |
|
0.0 |
|
0 |
|
|
|
|
fasting blood glucose, non fasting blood glucose |
106915 |
3071 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) then glucose |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
105.0 days
| 9 |
|
113.4 |
mg/dl |
5.4 |
16.2 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
0 |
min |
|
|
|
|
110746 |
3183 |
GK/MolTac |
blood glucose level |
control condition |
Kold-Petersen H, etal., J Vasc Res. 2012;49(3):267-78. doi: 10.1159/000335487. Epub 2012 Apr 11. |
blood glucose amount |
male |
112.0 days
| 0 |
|
190.8 |
mg/dl |
7.2 |
|
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
108035 |
3109 |
HanTac:WH |
blood glucose level |
control condition |
Kold-Petersen H, etal., J Vasc Res. 2012;49(3):267-78. doi: 10.1159/000335487. Epub 2012 Apr 11. |
blood glucose amount |
male |
154.0 days
| 0 |
|
102.6 |
mg/dl |
3.6 |
|
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
108036 |
3109 |
GK |
blood glucose level |
control condition |
Kondo H, etal., Muscle Nerve. 2015 Mar;51(3):391-9. doi: 10.1002/mus.24316. Epub 2015 Jan 6. |
blood glucose amount |
male |
63.0 days
| 6 |
|
270.0 |
mg/dl |
10.8 |
26.45 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
108044 |
3110 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) then glucose (for 1 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
105.0 days
| 9 |
|
273.6 |
mg/dl |
14.4 |
43.2 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
60 |
min |
|
|
|
|
110752 |
3183 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) then glucose (for 0.5 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
105.0 days
| 10 |
|
289.8 |
mg/dl |
21.6 |
68.31 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
30 |
min |
|
|
|
|
110748 |
3183 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
119.0 days
| 8 |
median |
109.8 |
mg/dl |
|
|
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
6.6; 5.7 75%; 25% |
|
|
110741 |
3183 |
HanTac:WH |
blood glucose level |
control condition |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
56.0 days
| 8 |
|
108.0 |
mg/dl |
1.8 |
5.09 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
110261 |
3168 |
GK/MolTac |
blood glucose level |
anti-rh-VEGF165 monoclonal antibody (1 mg) (for 42 days) |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
98.0 days
| 10 |
|
115.2 |
mg/dl |
1.8 |
5.69 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
110276 |
3168 |
BUF/MnaMcwi |
blood glucose level |
controlled ethanol content drinking water used as vehicle (0.1 %) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
male |
91.0 days
| 9 |
|
84.11 |
mg/dl |
2.71 |
8.12 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139283 |
3292 |
M520/NRrrcMcwi |
blood glucose level |
controlled ethanol content drinking water used as vehicle (0.1 %) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
female |
91.0 days
| 10 |
|
68.3 |
mg/dl |
2.02 |
6.4 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139670 |
3292 |
M520/NRrrcMcwi |
blood glucose level |
controlled ethanol content drinking water used as vehicle (0.1 %) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
male |
91.0 days
| 9 |
|
77.89 |
mg/dl |
2.35 |
7.04 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139799 |
3292 |
ACI/EurMcwi |
blood glucose level |
controlled ethanol content drinking water used as vehicle (0.1 %) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
female |
91.0 days
| 13 |
|
71.62 |
mg/dl |
3.16 |
11.39 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose, overnight fast, saphenous vien " |
Fasted blood glucose |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138660 |
3292 |
ACI/EurMcwi |
blood glucose level |
controlled bisphenol F content drinking water (1.125 mg/l) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
female |
91.0 days
| 10 |
|
74.4 |
mg/dl |
4.22 |
13.36 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
optical or electrochemical glucometer?; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138726 |
3292 |
WKY/N |
blood glucose level |
glucose solution (2 g/kg) |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood glucose amount |
both |
118.0 days-125.0 days |
220 |
|
138.24 |
mg/dl |
0.79 |
11.7 |
|
intraperitoneal glucose tolerance test |
|
0 |
glucose injection |
0 |
min |
|
|
|
|
65946 |
114 |
GK/KyoSwe |
blood glucose level |
fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) |
Galli J, et al., NatGenet 1996 Jan;12(1):31-7. |
blood glucose amount |
not specified |
65.0 days
| 22 |
|
140.4 |
mg/dl |
5.4 |
25.33 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
glucose injection |
0 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11384 |
82 |
F344/DuCrl |
blood glucose level |
fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) |
Galli J, et al., NatGenet 1996 Jan;12(1):31-7. |
blood glucose amount |
not specified |
65.0 days
| 10 |
|
93.6 |
mg/dl |
7.2 |
22.77 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
glucose injection |
60 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11395 |
82 |
F344/DuCrl |
blood glucose level |
fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) |
Galli J, et al., NatGenet 1996 Jan;12(1):31-7. |
blood glucose amount |
not specified |
65.0 days
| 10 |
|
64.8 |
mg/dl |
3.6 |
11.38 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
glucose injection |
120 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11396 |
82 |
F344/DuCrlCrlj |
blood glucose level |
control condition |
Ogino GenetRes 73:29 '99 |
blood glucose amount |
male |
42.0 days
| 9 |
|
102.6 |
mg/dl |
2.2 |
6.6 |
|
blood glucose test strip read by electrochemical glucometer |
tail |
0.0 |
|
0 |
|
Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan |
converted from mg/dl |
|
|
11426 |
84 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 11 |
|
100.8 |
mg/dl |
5.4 |
17.91 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
0 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11429 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 11 |
|
104.4 |
mg/dl |
3.6 |
11.94 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
0 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11430 |
85 |
F344/DuCrlCrlj |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 15 |
|
271.8 |
mg/dl |
9.0 |
34.86 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
15 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11440 |
85 |
F344/DuCrlCrlj |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 15 |
|
109.8 |
mg/dl |
3.6 |
13.94 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11431 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65.0 days
| 11 |
|
86.4 |
mg/dl |
1.8 |
5.97 |
|
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
0 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11452 |
85 |
F344/DuCrlCrlj |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65.0 days
| 15 |
|
86.4 |
mg/dl |
3.6 |
13.94 |
|
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11451 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65.0 days
| 11 |
|
190.8 |
mg/dl |
9.0 |
29.85 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
30 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11460 |
85 |
F344/NSlc |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 22 |
|
112.0 |
mg/dl |
2.2 |
10.32 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
60 |
min |
Arkray, Kyoto, Japan |
|
|
|
13208 |
230 |
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 16 |
|
127.0 |
mg/dl |
3.2 |
12.8 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
30 |
min |
Arkray, Kyoto, Japan |
|
|
|
13212 |
230 |
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 16 |
|
126.8 |
mg/dl |
2.7 |
10.8 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
90 |
min |
Arkray, Kyoto, Japan |
|
|
|
13214 |
230 |
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 16 |
|
124.8 |
mg/dl |
2.6 |
10.4 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
120 |
min |
Arkray, Kyoto, Japan |
|
|
|
13215 |
230 |
F344.OLETF-(D14Rat8-D14Rat26)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 15 |
|
114.8 |
mg/dl |
3.0 |
11.62 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
90 |
min |
Arkray, Kyoto, Japan |
|
|
|
13219 |
230 |
WBN/KobSlc |
blood glucose level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood glucose amount |
male |
120.0 days
| 5 |
|
313.5 |
mg/dl |
25.9 |
57.91 |
|
oral glucose tolerance test |
|
|
glucose challenge |
60 |
min |
glucose dose not specified |
serum glucose |
|
WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus |
12895 |
321 |
WBN/KobSlc |
blood glucose level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood glucose amount |
male |
120.0 days
| 5 |
|
266.7 |
mg/dl |
13.9 |
31.08 |
|
oral glucose tolerance test |
|
|
glucose challenge |
30 |
min |
glucose dose not specified |
serum glucose |
|
WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus |
12892 |
321 |
BN/CrlCrlj |
blood glucose level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood glucose amount |
male |
120.0 days
| 5 |
|
178.1 |
mg/dl |
7.9 |
17.66 |
|
oral glucose tolerance test |
|
|
glucose challenge |
30 |
min |
glucose dose not specified |
serum glucose |
|
WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus |
12908 |
321 |
F344/NSlc |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420.0 days
| 7 |
|
134.1 |
mg/dl |
4.7 |
12.44 |
|
oral glucose tolerance test |
|
0 |
oral dose |
15 |
min |
|
|
|
|
13157 |
106 |
F344/NSlc |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420.0 days
| 7 |
|
99.0 |
mg/dl |
4.48 |
11.85 |
|
oral glucose tolerance test |
|
0 |
oral dose |
0 |
min |
|
|
|
|
13156 |
106 |
F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 13 |
|
89.8 |
mg/dl |
2.2 |
7.93 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
0 |
min |
Arkray, Kyoto, Japan |
|
|
|
13226 |
230 |
F344.OLETF-(D1Mit20-D1Mgh26)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 15 |
|
108.2 |
mg/dl |
2.9 |
11.23 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
30 |
min |
Arkray, Kyoto, Japan |
|
|
|
13232 |
230 |
F344.OLETF-(D1Mit20-D1Mgh26)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 15 |
|
89.5 |
mg/dl |
2.2 |
8.52 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
0 |
min |
Arkray, Kyoto, Japan |
|
|
|
13231 |
230 |
F344.OLETF-(D9Mgh8-D9Mit2)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 8 |
|
100.1 |
mg/dl |
2.4 |
6.79 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
30 |
min |
Arkray, Kyoto, Japan |
|
|
|
13247 |
230 |
F344.OLETF-(D14Rat8-D14Rat26)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 14 |
|
118.3 |
mg/dl |
1.7 |
6.36 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
60 |
min |
Arkray, Kyoto, Japan |
|
|
|
13258 |
230 |
F344.OLETF-(D16Wox4-D16Rat13)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 10 |
|
89.0 |
mg/dl |
2.4 |
7.59 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
0 |
min |
Arkray, Kyoto, Japan |
|
|
|
13261 |
230 |
F344.OLETF-(D10Wox7-D10Wox6)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 7 |
|
100.9 |
mg/dl |
3.0 |
7.94 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
30 |
min |
Arkray, Kyoto, Japan |
|
|
|
13267 |
230 |
F344/DuCrlCrlj |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 20 |
|
334.8 |
mg/dl |
|
|
|
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
15 |
min |
|
|
|
|
67648 |
85 |
N:HS |
blood glucose level |
glucose solution (2 g/kg) |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood glucose amount |
both |
118.0 days-125.0 days |
220 |
|
109.8 |
mg/dl |
0.07 |
1.08 |
|
intraperitoneal glucose tolerance test |
|
0 |
glucose injection |
120 |
min |
|
|
|
|
65979 |
114 |
BB.SHR-(D6Rat184-D6Rat3)/K |
blood glucose level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood glucose amount |
both |
84.0 days
| 32 |
|
105.0 |
mg/dl |
1.77 |
10.0 |
|
automated blood analysis |
opthalmic venous plexus |
0.0 |
|
0 |
|
|
|
|
|
70110 |
324 |
SD |
blood glucose level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
female |
85.0 days-99.0 days |
6 |
|
90.83 |
mg/dl |
4.2 |
10.28 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
Siemens biochemical analyzer |
|
|
|
84998 |
1602 |
LL/Mav |
blood glucose level |
vehicle control condition then fasting (for 16 hours) then glucose (2 g/kg) (for 1 hours) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood glucose amount |
male |
56.0 days
| 9 |
|
136.0 |
mg/dl |
4.0 |
12.0 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
102718 |
2721 |
OLETF |
blood glucose level |
olmesartan medoxomil (3.8 mg/kg/d) (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
blood glucose amount |
male |
364.0 days
| 12 |
|
188.82 |
mg/dl |
6.84 |
23.69 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
99418 |
2298 |
GK |
blood glucose level |
fasting (for 16 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
blood glucose amount |
male |
134.0 days
| 6 |
|
156.0 |
mg/dl |
12.0 |
29.39 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103508 |
2827 |
WKY/NCrl |
blood glucose level |
salidroside (40 mg/kg) (for 28 days) then fasting (for 16 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
blood glucose amount |
male |
168.0 days
| 6 |
|
103.0 |
mg/dl |
3.0 |
7.35 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103511 |
2827 |
SS-Nppbem2Mcwi+/+ |
blood glucose level |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
blood glucose amount |
male |
252.0 days
| 6 |
|
183.2 |
mg/dl |
37.8 |
92.59 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
99752 |
2319 |
SS-Nppbem2Mcwi-/- |
blood glucose level |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
blood glucose amount |
male |
252.0 days
| 6 |
|
160.3 |
mg/dl |
16.4 |
40.17 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
99753 |
2319 |
Crl:WI(Han) |
blood glucose level |
sham surgical control condition (for 24 days) then fasting (for 12 hours) |
Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31. |
blood glucose amount |
female |
87.0 days
| 6 |
|
105.0 |
mg/dl |
3.0 |
7.35 |
|
machine read blood glucose test strip |
|
0.0 |
|
0 |
|
|
|
|
|
103757 |
2782 |
LL/Mav |
blood glucose level |
vehicle control condition then fasting (for 16 hours) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood glucose amount |
male |
49.0 days-56.0 days |
13 |
|
65.0 |
mg/dl |
1.0 |
3.61 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
102656 |
2703 |
Jcl:WI |
blood glucose level |
control condition then fasting (for 12 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
31.0 days
| 6 |
|
52.0 |
mg/dl |
3.79 |
9.28 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103916 |
2884 |
GK/Jcl |
blood glucose level |
control condition then fasting (for 0 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
31.0 days
| 6 |
|
113.71 |
mg/dl |
5.32 |
13.03 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103917 |
2884 |
GK/Jcl |
blood glucose level |
controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 7 days) then fasting (for 12 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
31.0 days
| 6 |
|
84.14 |
mg/dl |
2.38 |
5.83 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103919 |
2884 |
Jcl:WI |
blood glucose level |
control condition then fasting (for 0 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
38.0 days
| 6 |
|
91.71 |
mg/dl |
3.2 |
7.84 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103920 |
2884 |
GK/Jcl |
blood glucose level |
control condition then fasting (for 0 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
38.0 days
| 6 |
|
122.1 |
mg/dl |
2.58 |
6.32 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103921 |
2884 |
GK/Jcl |
blood glucose level |
controlled hesperidin content diet (1 %) (for 14 days) then fasting (for 0 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
38.0 days
| 6 |
|
99.85 |
mg/dl |
1.8 |
4.41 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103922 |
2884 |
GK/Jcl |
blood glucose level |
control condition then fasting (for 0 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
45.0 days
| 6 |
|
144.42 |
mg/dl |
5.26 |
12.88 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103925 |
2884 |
GK/Jcl |
blood glucose level |
controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 21 days) then fasting (for 12 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
45.0 days
| 6 |
|
128.28 |
mg/dl |
5.86 |
14.35 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103927 |
2884 |
WKY |
blood glucose level |
streptozotocin (60 mg/kg) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 null) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
blood glucose amount |
male |
156.0 days
| 10 |
|
523.26 |
mg/dl |
27.18 |
85.95 |
|
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
|
|
99104 |
2219 |
GK/MolTac |
blood glucose level |
control condition |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood glucose amount |
male |
144.0 days
| 12 |
|
352.0 |
mg/dl |
39.0 |
135.1 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
103992 |
2885 |
SDT/Jcl |
blood glucose level |
nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) and paricalcitol (0.3 ug/kg) (for 70 days) |
Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. |
blood glucose amount |
male |
140.0 days
| 6 |
|
132.1 |
mg/dl |
12.3 |
30.13 |
|
blood glucose analysis |
|
0.0 |
unx |
84 |
days |
|
|
|
|
100123 |
2419 |
SD |
blood glucose level |
nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) and paricalcitol (0.1 ug/kg) (for 70 days) |
Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. |
blood glucose amount |
male |
140.0 days
| 8 |
|
137.7 |
mg/dl |
8.3 |
23.48 |
|
blood glucose analysis |
|
0.0 |
unx |
84 |
days |
|
|
|
|
100122 |
2419 |
GK/MolTac |
blood glucose level |
sodium chloride solution (for 23 days) then control condition (for 20 days) then fasting (for 16 hours) then glucose solution (2 g/kg) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood glucose amount |
male |
122.0 days-129.0 days |
4 |
|
162.0 |
mg/dl |
14.0 |
28.0 |
|
oral glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
103808 |
2864 |
SD |
blood glucose level |
control condition |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
blood glucose amount |
male |
0.0 days
| 8 |
|
98.0 |
mg/dl |
3.18 |
9.0 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
99922 |
2358 |
SD |
blood glucose level |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
blood glucose amount |
male |
0.0 days
| 8 |
|
350.0 |
mg/dl |
19.09 |
54.0 |
|
blood glucose analysis |
|
0.0 |
stz |
224 |
days |
|
|
|
|
99921 |
2358 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0.0 days
| 8 |
|
350.0 |
mg/dl |
18.0 |
50.91 |
|
machine read blood glucose test strip |
|
0.0 |
unx |
28 |
days |
|
|
|
|
99941 |
2378 |
SD-Lepem1Sage-/- |
blood glucose level |
fasting (for 16 hours) then standard diet (for 1 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood glucose amount |
male |
91.0 days
| 6 |
|
185.76 |
mg/dl |
16.74 |
41.0 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
104471 |
2949 |
SD-Lepem1Sage-/- |
blood glucose level |
fasting (for 16 hours) then standard diet (for 1 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood glucose amount |
female |
91.0 days
| 6 |
|
216.0 |
mg/dl |
23.4 |
57.32 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
104473 |
2949 |
Crl:WI |
blood glucose level |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
84.0 days
| 8 |
|
115.2 |
mg/dl |
4.45 |
12.6 |
|
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
|
|
104076 |
2907 |
MNS |
blood glucose level |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
168.0 days
| 8 |
|
115.2 |
mg/dl |
3.82 |
10.8 |
|
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
|
|
104077 |
2907 |
MHS |
blood glucose level |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
168.0 days
| 8 |
|
115.2 |
mg/dl |
3.18 |
9.0 |
|
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
|
|
104079 |
2907 |
MNS |
blood glucose level |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
252.0 days
| 14 |
|
113.4 |
mg/dl |
2.41 |
9.0 |
|
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
|
|
104081 |
2907 |
MHS |
blood glucose level |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
252.0 days
| 14 |
|
478.8 |
mg/dl |
12.51 |
46.8 |
|
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
|
|
104084 |
2907 |
SS/JrHsdMcwi |
blood glucose level |
fasting (for 12 hours) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
blood glucose amount |
male |
84.0 days
| 8 |
|
114.0 |
mg/dl |
3.0 |
8.49 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
105862 |
3023 |
SS/JrHsdMcwi |
blood glucose level |
fasting (for 12 hours) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
blood glucose amount |
male |
140.0 days-168.0 days |
8 |
|
102.0 |
mg/dl |
2.0 |
5.66 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
105864 |
3023 |
SBH/Ygl |
blood glucose level |
controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
blood glucose amount |
male |
98.0 days
| 7 |
|
361.8 |
mg/dl |
32.4 |
85.72 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
106695 |
3038 |
GK/MolTac |
blood glucose level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood glucose amount |
female |
420.0 days
| 11 |
|
289.8 |
mg/dl |
10.8 |
35.82 |
|
blood glucose test strip read by optical glucometer |
|
0.0 |
|
0 |
|
|
|
|
fasting blood glucose, non fasting blood glucose |
106907 |
3071 |
W/Jpe |
blood glucose level |
control condition then fasting (for 15 hours) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
blood glucose amount |
male |
540.0 days
| 20 |
|
75.6 |
mg/dl |
1.9 |
8.5 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
108004 |
3108 |
GK/Jpe |
blood glucose level |
controlled cocoa butter content diet (7.5 %) (for 90 days) and controlled cholesterol content diet (1.25 %) (for 90 days) and lipoic acid (50 mg/kg) then fasting (for 15 hours) |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
blood glucose amount |
male |
540.0 days
| 7 |
|
122.04 |
mg/dl |
5.4 |
14.29 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
110864 |
3193 |
GK/MolTac |
blood glucose level |
fasting (for 6 hours) |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood glucose amount |
female |
60.0 days
| 6 |
|
144.0 |
mg/dl |
7.2 |
17.64 |
|
blood glucose test strip read by optical glucometer |
|
0.0 |
|
0 |
|
|
|
|
fasting blood glucose, non fasting blood glucose |
106911 |
3071 |
Slc:ZUC-Leprfa+ |
blood glucose level |
fasting (for 17 hours) |
Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412. |
blood glucose amount |
male |
84.0 days-105.0 days |
9 |
|
98.6 |
mg/dl |
2.4 |
7.2 |
|
automated plasma glucose analysis |
|
0.0 |
|
0 |
|
|
slc:zuc-leprfa+ |
|
|
108661 |
3070 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) then glucose (for 0.5 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
105.0 days
| 8 |
|
250.2 |
mg/dl |
21.6 |
61.09 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
30 |
min |
|
|
|
|
110747 |
3183 |
HanTac:WH |
blood glucose level |
control condition |
Kold-Petersen H, etal., J Vasc Res. 2012;49(3):267-78. doi: 10.1159/000335487. Epub 2012 Apr 11. |
blood glucose amount |
male |
112.0 days
| 0 |
|
95.4 |
mg/dl |
1.8 |
|
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
108034 |
3109 |
GK |
blood glucose level |
running on treadmill (15 m/min) (for 1 hours) |
Kondo H, etal., Muscle Nerve. 2015 Mar;51(3):391-9. doi: 10.1002/mus.24316. Epub 2015 Jan 6. |
blood glucose amount |
male |
63.0 days
| 6 |
|
268.2 |
mg/dl |
23.4 |
57.32 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
108045 |
3110 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) then glucose (for 1 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
105.0 days
| 8 |
|
262.8 |
mg/dl |
23.4 |
66.19 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
60 |
min |
|
|
|
|
110750 |
3183 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) then glucose (for 1.5 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
105.0 days
| 9 |
|
244.8 |
mg/dl |
12.6 |
37.8 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
90 |
min |
|
|
|
|
110755 |
3183 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) then glucose (for 2 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
105.0 days
| 10 |
|
234.0 |
mg/dl |
9.0 |
28.46 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
120 |
min |
|
|
|
|
110757 |
3183 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
112.0 days
| 9 |
median |
126.0 |
mg/dl |
|
|
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
9.0; 6.2 75%; 25% |
|
|
110740 |
3183 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) then glucose |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
105.0 days
| 8 |
|
120.6 |
mg/dl |
3.6 |
10.18 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
0 |
min |
|
|
|
|
110744 |
3183 |
GK/MolTac |
blood glucose level |
control IgG monoclonal antibody (1 mg) (for 42 days) |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
98.0 days
| 9 |
|
129.6 |
mg/dl |
5.4 |
16.2 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
110275 |
3168 |
HanTac:WH |
blood glucose level |
control IgG monoclonal antibody (1 mg) (for 14 days) |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
70.0 days
| 8 |
|
108.0 |
mg/dl |
3.6 |
10.18 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
110265 |
3168 |
GK/MolTac |
blood glucose level |
anti-rh-VEGF165 monoclonal antibody (1 mg) (for 14 days) |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
70.0 days
| 10 |
|
131.4 |
mg/dl |
7.2 |
22.77 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
110268 |
3168 |
HanTac:WH |
blood glucose level |
anti-rh-VEGF165 monoclonal antibody (1 mg) (for 28 days) |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
84.0 days
| 8 |
|
111.6 |
mg/dl |
3.6 |
10.18 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
110270 |
3168 |
W/Jpe |
blood glucose level |
fasting (for 15 hours) then glucose solution (1.75 g/kg) (for 2 hours) |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
blood glucose amount |
male |
540.0 days
| 7 |
|
117.0 |
mg/dl |
10.8 |
28.57 |
|
intraperitoneal glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
110865 |
3193 |
ACI/EurMcwi |
blood glucose level |
controlled bisphenol F content drinking water (1.125 mg/l) (between 49 and 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
male |
91.0 days
| 12 |
|
74.08 |
mg/dl |
1.79 |
6.2 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien, animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
138855 |
3292 |
BN/NHsdMcwi |
blood glucose level |
controlled bisphenol F content drinking water (1.125 mg/l) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
male |
91.0 days
| 11 |
|
72.36 |
mg/dl |
1.6 |
5.3 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien , animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139091 |
3292 |
F344/StmMcwi |
blood glucose level |
controlled bisphenol F content drinking water (1.125 mg/l) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
male |
91.0 days
| 11 |
|
96.0 |
mg/dl |
2.77 |
9.19 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139607 |
3292 |
M520/NRrrcMcwi |
blood glucose level |
controlled bisphenol F content drinking water (1.125 mg/l) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
female |
91.0 days
| 8 |
|
71.75 |
mg/dl |
2.34 |
6.63 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139736 |
3292 |
WKY/NCrl |
blood glucose level |
controlled bisphenol F content drinking water (1.125 mg/l) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
male |
91.0 days
| 15 |
|
69.13 |
mg/dl |
1.44 |
5.59 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
140123 |
3292 |
F344/DuCrlCrlj |
blood glucose level |
partial pancreatectomy (70 %) |
Ogino GenetRes 73:29 '99 |
blood glucose amount |
male |
63.0 days
| 9 |
|
109.9 |
mg/dl |
1.6 |
4.8 |
|
blood glucose test strip read by electrochemical glucometer |
tail |
0.0 |
post pancreatectomy |
21 |
days |
Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan |
converted from mg/dl |
|
|
11417 |
84 |
F344/DuCrlCrlj |
blood glucose level |
partial pancreatectomy (70 %) |
Ogino GenetRes 73:29 '99 |
blood glucose amount |
male |
49.0 days
| 9 |
|
123.4 |
mg/dl |
2.2 |
6.6 |
|
blood glucose test strip read by electrochemical glucometer |
tail |
0.0 |
post pancreatectomy |
7 |
days |
Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan |
converted from mg/dl |
|
|
11419 |
84 |
OLETF/Got |
blood glucose level |
partial pancreatectomy (70 %) |
Ogino GenetRes 73:29 '99 |
blood glucose amount |
male |
56.0 days
| 13 |
|
251.2 |
mg/dl |
27.1 |
97.71 |
|
blood glucose test strip read by electrochemical glucometer |
tail |
0.0 |
post pancreatectomy |
14 |
days |
Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan |
converted from mg/dl |
|
|
11423 |
84 |
OLETF/Got |
blood glucose level |
partial pancreatectomy (70 %) |
Ogino GenetRes 73:29 '99 |
blood glucose amount |
male |
70.0 days
| 13 |
|
279.3 |
mg/dl |
41.4 |
149.27 |
|
blood glucose test strip read by electrochemical glucometer |
tail |
0.0 |
post pancreatectomy |
28 |
days |
Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan |
converted from mg/dl |
|
|
11425 |
84 |
F344/DuCrlCrlj |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 15 |
|
91.8 |
mg/dl |
1.8 |
6.97 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
0 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11428 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65.0 days
| 11 |
|
84.6 |
mg/dl |
1.8 |
5.97 |
|
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
0 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11449 |
85 |
F344/DuCrlCrlj |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65.0 days
| 15 |
|
86.4 |
mg/dl |
1.8 |
6.97 |
|
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
0 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11450 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65.0 days
| 11 |
|
91.8 |
mg/dl |
1.8 |
5.97 |
|
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11456 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
185.0 days
| 10 |
|
111.6 |
mg/dl |
1.8 |
5.69 |
|
blood glucose analysis |
tail vein |
|
|
0 |
|
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11481 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
185.0 days
| 10 |
|
102.6 |
mg/dl |
1.8 |
5.69 |
|
blood glucose analysis |
tail vein |
|
|
0 |
|
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11480 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 11 |
|
313.2 |
mg/dl |
12.6 |
41.79 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
15 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11441 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 11 |
|
252.0 |
mg/dl |
7.2 |
23.88 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
30 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11438 |
85 |
F344.GK-(D1Rat175-D1Rat90)/Swe |
blood glucose level |
fasting (for 6 hours) then glucose solution (2 g/kg) |
Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. |
blood glucose amount |
male |
95.0 days
| 12 |
|
336.6 |
mg/dl |
10.8 |
37.41 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
30 |
min |
|
|
|
|
13097 |
330 |
F344.GK-(D1Mgh14-D1Rat90)/Swe |
blood glucose level |
fasting (for 6 hours) then glucose solution (2 g/kg) |
Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. |
blood glucose amount |
male |
95.0 days
| 12 |
|
333.0 |
mg/dl |
14.4 |
49.88 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
15 |
min |
|
|
|
|
13106 |
330 |
F344.GK-(D1Got250-D1Rat90)/Swe |
blood glucose level |
fasting (for 6 hours) then glucose solution (2 g/kg) |
Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. |
blood glucose amount |
male |
95.0 days
| 12 |
|
279.0 |
mg/dl |
9.0 |
31.18 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
30 |
min |
|
|
|
|
13103 |
330 |
F344.GK-(D1Swe4-D1Rat85)/Swe |
blood glucose level |
fasting (for 6 hours) then glucose solution (2 g/kg) |
Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. |
blood glucose amount |
male |
95.0 days
| 12 |
|
205.2 |
mg/dl |
10.8 |
37.41 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
30 |
min |
|
|
|
|
13115 |
330 |
F344.OLETF-(D14Rat8-D14Rat26)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 15 |
|
114.6 |
mg/dl |
3.2 |
12.39 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
30 |
min |
Arkray, Kyoto, Japan |
|
|
|
13217 |
230 |
F344.OLETF-(D14Rat8-D14Rat26)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 15 |
|
116.4 |
mg/dl |
2.9 |
11.23 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
60 |
min |
Arkray, Kyoto, Japan |
|
|
|
13218 |
230 |
F344.OLETF-(D8Rat54-D8Mgh17)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 19 |
|
125.4 |
mg/dl |
3.2 |
13.95 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
60 |
min |
Arkray, Kyoto, Japan |
|
|
|
13223 |
230 |
WBN/KobSlc |
blood glucose level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood glucose amount |
male |
120.0 days
| 5 |
|
140.2 |
mg/dl |
13.4 |
29.96 |
|
oral glucose tolerance test |
|
|
glucose challenge |
0 |
min |
|
serum glucose |
|
WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus |
12887 |
321 |
WBN/KobSlc |
blood glucose level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood glucose amount |
male |
120.0 days
| 5 |
|
216.9 |
mg/dl |
8.6 |
19.23 |
|
oral glucose tolerance test |
|
|
glucose challenge |
120 |
min |
glucose dose not specified |
serum glucose |
|
WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus |
12896 |
321 |
BN/CrlCrlj |
blood glucose level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood glucose amount |
male |
120.0 days
| 5 |
|
145.1 |
mg/dl |
16.4 |
36.67 |
|
oral glucose tolerance test |
|
|
glucose challenge |
0 |
min |
|
serum glucose |
|
WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus |
12907 |
321 |
BB.SHR-(D6Rat184-D6Rat3)/K |
blood glucose level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood glucose amount |
both |
84.0 days
| 46 |
|
106.0 |
mg/dl |
2.36 |
16.0 |
|
automated blood analysis |
opthalmic venous plexus |
0.0 |
|
0 |
|
|
|
|
|
12979 |
324 |
F344/NSlc |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420.0 days
| 7 |
|
157.0 |
mg/dl |
5.21 |
13.78 |
|
oral glucose tolerance test |
|
0 |
oral dose |
60 |
min |
|
|
|
|
13159 |
106 |
SDT/Jcl |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420.0 days
| 5 |
|
702.8 |
mg/dl |
25.39 |
56.77 |
|
oral glucose tolerance test |
|
0 |
oral dose |
60 |
min |
|
|
|
|
13167 |
106 |
F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 13 |
|
122.6 |
mg/dl |
3.1 |
11.18 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
120 |
min |
Arkray, Kyoto, Japan |
|
|
|
13230 |
230 |
F344.OLETF-(D1Mit20-D1Mgh26)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 15 |
|
110.4 |
mg/dl |
2.8 |
10.84 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
60 |
min |
Arkray, Kyoto, Japan |
|
|
|
13233 |
230 |
F344.OLETF-(D1Rat166-D1Rat90)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 12 |
|
111.5 |
mg/dl |
2.1 |
7.27 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
120 |
min |
Arkray, Kyoto, Japan |
|
|
|
13240 |
230 |
F344.OLETF-(D5Mgh4-D5Rat21)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 10 |
|
115.3 |
mg/dl |
2.2 |
6.96 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
60 |
min |
Arkray, Kyoto, Japan |
|
|
|
13243 |
230 |
F344.OLETF-(D12Wox5-D12Rat21)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 13 |
|
84.4 |
mg/dl |
1.5 |
5.41 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
0 |
min |
Arkray, Kyoto, Japan |
|
|
|
13251 |
230 |
F344.OLETF-(D14Rat8-D14Rat26)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 14 |
|
114.8 |
mg/dl |
1.9 |
7.11 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
30 |
min |
Arkray, Kyoto, Japan |
|
|
|
13257 |
230 |
F344.OLETF-(D14Rat8-D14Rat26)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 14 |
|
119.0 |
mg/dl |
2.0 |
7.48 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
90 |
min |
Arkray, Kyoto, Japan |
|
|
|
13259 |
230 |
F344.OLETF-(D16Wox4-D16Rat13)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 10 |
|
105.9 |
mg/dl |
2.6 |
8.22 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
30 |
min |
Arkray, Kyoto, Japan |
|
|
|
13262 |
230 |
F344.OLETF-(D16Wox4-D16Rat13)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 10 |
|
102.0 |
mg/dl |
2.6 |
8.22 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
120 |
min |
Arkray, Kyoto, Japan |
|
|
|
13265 |
230 |
F344.OLETF-(D16Wox4-D16Rat13)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 10 |
|
102.2 |
mg/dl |
2.4 |
7.59 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
90 |
min |
Arkray, Kyoto, Japan |
|
|
|
13264 |
230 |
F344.OLETF-(D10Wox7-D10Wox6)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 7 |
|
105.6 |
mg/dl |
2.4 |
6.35 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
60 |
min |
Arkray, Kyoto, Japan |
|
|
|
13268 |
230 |
WOKW |
blood glucose level |
glucose solution (2 g/kg) |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
blood glucose amount |
female |
0.0 days
| 12 |
|
91.0 |
mg/dl |
|
|
|
intraperitoneal glucose tolerance test |
|
0.0 |
intraperitoneal injection |
0 |
min |
glucose analyser (Medingen ESAT 6660-2, Germany) |
average of measures taken at 196 days, 210 days and 224 days |
|
|
13271 |
251 |
F344.OLETF-(D10Wox7-D10Wox6)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 7 |
|
103.7 |
mg/dl |
1.2 |
3.17 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
120 |
min |
Arkray, Kyoto, Japan |
|
|
|
13270 |
230 |
F344/DuCrlCrlj |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 20 |
|
90.0 |
mg/dl |
|
|
|
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
0 |
min |
|
|
|
|
67647 |
85 |
WKY/N |
blood glucose level |
glucose solution (2 g/kg) |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood glucose amount |
both |
118.0 days-125.0 days |
220 |
|
406.8 |
mg/dl |
4.67 |
69.3 |
|
intraperitoneal glucose tolerance test |
|
0 |
glucose injection |
30 |
min |
|
|
|
|
65976 |
114 |
SD |
blood glucose level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
male |
71.0 days-85.0 days |
6 |
|
127.0 |
mg/dl |
8.82 |
21.6 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
Siemens biochemical analyzer |
|
|
|
84989 |
1602 |
SD |
blood glucose level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
male |
85.0 days-99.0 days |
6 |
|
72.48 |
mg/dl |
12.78 |
31.31 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
Siemens biochemical analyzer |
|
|
|
84991 |
1602 |
SD |
blood glucose level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
male |
71.0 days-85.0 days |
6 |
|
86.8 |
mg/dl |
4.51 |
11.05 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
Siemens biochemical analyzer |
|
|
|
84990 |
1602 |
SD |
blood glucose level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
female |
71.0 days-85.0 days |
6 |
|
116.2 |
mg/dl |
9.03 |
22.13 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
Siemens biochemical analyzer |
|
|
|
84995 |
1602 |
LETO |
blood glucose level |
control condition (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
blood glucose amount |
male |
364.0 days
| 11 |
|
135.72 |
mg/dl |
2.7 |
8.95 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
99420 |
2298 |
LH/Mav |
blood glucose level |
vehicle control condition then fasting (for 16 hours) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood glucose amount |
male |
56.0 days
| 11 |
|
69.0 |
mg/dl |
1.0 |
3.32 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
102716 |
2721 |
LH/Mav |
blood glucose level |
vehicle control condition then fasting (for 16 hours) then glucose (2 g/kg) (for 1 hours) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood glucose amount |
male |
56.0 days
| 11 |
|
127.0 |
mg/dl |
3.0 |
9.95 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
102720 |
2721 |
Jcl:WI |
blood glucose level |
Omacor (400 mg/kg/d) (for 56 days) |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
blood glucose amount |
male |
84.0 days
| 8 |
|
145.44 |
mg/dl |
15.08 |
42.66 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
103072 |
2785 |
WKY/NCrl |
blood glucose level |
fasting (for 16 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
blood glucose amount |
male |
134.0 days
| 6 |
|
100.0 |
mg/dl |
3.0 |
7.35 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103506 |
2827 |
GK |
blood glucose level |
fasting (for 16 hours) then glucose (2 g/kg) (for 2 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
blood glucose amount |
male |
134.0 days
| 6 |
|
331.0 |
mg/dl |
30.0 |
73.48 |
|
oral glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
103517 |
2827 |
GK |
blood glucose level |
fasting (for 16 hours) then glucose (2 g/kg) (for 2 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
blood glucose amount |
male |
134.0 days
| 6 |
|
301.0 |
mg/dl |
23.0 |
56.34 |
|
oral glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
103516 |
2827 |
WKY/NCrl |
blood glucose level |
vehicle control condition (for 28 days) then fasting (for 16 hours) then glucose (2 g/kg) (for 2 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
blood glucose amount |
male |
168.0 days
| 6 |
|
125.0 |
mg/dl |
3.0 |
7.35 |
|
oral glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
103518 |
2827 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0.0 days
| 17 |
|
324.0 |
mg/dl |
13.0 |
53.6 |
|
machine read blood glucose test strip |
|
0.0 |
unx |
168 |
days |
|
|
|
|
99971 |
2378 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0.0 days
| 11 |
|
76.0 |
mg/dl |
1.0 |
3.32 |
|
machine read blood glucose test strip |
|
0.0 |
unx |
168 |
days |
|
|
|
|
99970 |
2378 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0.0 days
| 17 |
|
312.0 |
mg/dl |
24.0 |
98.95 |
|
machine read blood glucose test strip |
|
0.0 |
unx |
168 |
days |
|
|
|
|
99972 |
2378 |
Crlj:WI |
blood glucose level |
controlled air oxygen content (5 %) (for 28 days) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
blood glucose amount |
male |
16.0 days
| 7 |
|
115.2 |
mg/dl |
7.2 |
19.05 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
103004 |
2784 |
GK |
blood glucose level |
controlled air oxygen content (5 %) (for 28 days) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
blood glucose amount |
male |
16.0 days
| 7 |
|
201.6 |
mg/dl |
10.8 |
28.57 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
103006 |
2784 |
Crl:WI(Han) |
blood glucose level |
bilateral ovariectomy (for 24 days) then fasting (for 12 hours) |
Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31. |
blood glucose amount |
female |
87.0 days
| 6 |
|
97.0 |
mg/dl |
2.0 |
4.9 |
|
machine read blood glucose test strip |
|
0.0 |
|
0 |
|
|
|
|
|
103758 |
2782 |
GK/MolTac |
blood glucose level |
fasting (for 16 hours) then glucose solution (2 g/kg) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood glucose amount |
male |
70.0 days-77.0 days |
6 |
|
209.0 |
mg/dl |
4.9 |
12.0 |
|
oral glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
103804 |
2864 |
GK/MolTac |
blood glucose level |
rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 16 hours) then glucose solution (2 g/kg) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood glucose amount |
male |
95.0 days-102.0 days |
3 |
|
146.0 |
mg/dl |
3.46 |
6.0 |
|
oral glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
103806 |
2864 |
GK/MolTac |
blood glucose level |
rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 16 hours) then glucose solution (2 g/kg) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood glucose amount |
male |
95.0 days-102.0 days |
4 |
|
142.0 |
mg/dl |
4.0 |
8.0 |
|
oral glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
103807 |
2864 |
LH/MavRrrcAek |
blood glucose level |
controlled sodium content diet (0.3 %) (for 105 days) then controlled sodium content diet (4 %) (for 21 days) |
Ma MCJ, et al., PLoS One. 2017 Aug 8;12(8):e0182650. doi: 10.1371/journal.pone.0182650. eCollection 2017. |
blood glucose amount |
male |
126.0 days
| 20 |
|
88.0 |
mg/dl |
3.4 |
15.21 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
102778 |
2722 |
LH.LH-Chr 17LN-(rs199194111-rs105876746)/Aek |
blood glucose level |
controlled sodium content diet (0.3 %) (for 105 days) then controlled sodium content diet (4 %) (for 21 days) |
Ma MCJ, et al., PLoS One. 2017 Aug 8;12(8):e0182650. doi: 10.1371/journal.pone.0182650. eCollection 2017. |
blood glucose amount |
male |
126.0 days
| 6 |
|
83.0 |
mg/dl |
6.4 |
15.68 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
102780 |
2722 |
LH/Mav |
blood glucose level |
vehicle control condition then fasting (for 16 hours) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood glucose amount |
male |
49.0 days-56.0 days |
8 |
|
67.0 |
mg/dl |
1.0 |
2.83 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
102657 |
2703 |
LH/Mav |
blood glucose level |
streptozotocin (75 mg/kg) then fasting (for 16 hours) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood glucose amount |
male |
49.0 days-56.0 days |
37 |
|
70.0 |
mg/dl |
1.0 |
6.08 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
102658 |
2703 |
LH/Mav |
blood glucose level |
streptozotocin (75 mg/kg) then fasting (for 16 hours) then glucose (2 g/kg) (for 1 hours) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood glucose amount |
male |
49.0 days-56.0 days |
37 |
|
300.0 |
mg/dl |
8.0 |
48.66 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
102661 |
2703 |
GK/Jcl |
blood glucose level |
controlled hesperidin content diet (1 %) (for 21 days) then fasting (for 0 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
45.0 days
| 6 |
|
127.36 |
mg/dl |
4.77 |
11.68 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103926 |
2884 |
GK/Jcl |
blood glucose level |
controlled hesperidin content diet (1 %) (for 28 days) then fasting (for 0 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
52.0 days
| 6 |
|
104.14 |
mg/dl |
4.03 |
9.87 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103930 |
2884 |
WKY |
blood glucose level |
streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 null) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
blood glucose amount |
male |
156.0 days
| 10 |
|
534.6 |
mg/dl |
22.5 |
71.15 |
|
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
|
|
99106 |
2219 |
Crl:WI |
blood glucose level |
control condition |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood glucose amount |
male |
144.0 days
| 6 |
|
170.0 |
mg/dl |
16.0 |
39.19 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
103987 |
2885 |
Crl:WI |
blood glucose level |
running on treadmill (0-10 m/min) (between 0.1 and 0.2 hours) then running on treadmill (15 m/min) (for 0.5 hours) then running on treadmill (15 m/min) (for 0.8 hours) |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood glucose amount |
male |
144.0 days
| 6 |
|
162.0 |
mg/dl |
8.0 |
19.6 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
103988 |
2885 |
GK/MolTac |
blood glucose level |
running on treadmill (0-10 m/min) (between 0.1 and 0.2 hours) then running on treadmill (15 m/min) (for 0.5 hours) then running on treadmill (15 m/min) (for 0.8 hours) |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood glucose amount |
male |
144.0 days
| 6 |
|
290.0 |
mg/dl |
30.0 |
73.48 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
103991 |
2885 |
GK/MolTac |
blood glucose level |
running on treadmill (0-10 m/min) (between 0.1 and 0.2 hours) then running on treadmill (15 m/min) (for 0.5 hours) then running on treadmill (15 m/min) (for 0.8 hours) |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood glucose amount |
male |
144.0 days
| 12 |
|
282.0 |
mg/dl |
17.0 |
58.89 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
103993 |
2885 |
SDT/Jcl |
blood glucose level |
nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) |
Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. |
blood glucose amount |
male |
140.0 days
| 6 |
|
140.0 |
mg/dl |
6.8 |
16.66 |
|
blood glucose analysis |
|
0.0 |
unx |
84 |
days |
|
|
|
|
100119 |
2419 |
SD |
blood glucose level |
nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) |
Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. |
blood glucose amount |
male |
140.0 days
| 6 |
|
134.7 |
mg/dl |
5.9 |
14.45 |
|
blood glucose analysis |
|
0.0 |
unx |
84 |
days |
|
|
|
|
100120 |
2419 |
SD |
blood glucose level |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
blood glucose amount |
male |
0.0 days
| 8 |
|
358.0 |
mg/dl |
20.86 |
59.0 |
|
blood glucose analysis |
|
0.0 |
stz |
224 |
days |
|
|
|
|
99920 |
2358 |
SD-Lepem1Sage+/+ |
blood glucose level |
fasting (for 16 hours) then standard diet (for 1 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood glucose amount |
male |
91.0 days
| 6 |
|
109.08 |
mg/dl |
3.6 |
8.82 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
104470 |
2949 |
Crl:WI |
blood glucose level |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
252.0 days
| 10 |
|
113.4 |
mg/dl |
1.71 |
5.4 |
|
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
|
|
104085 |
2907 |
Crl:WI |
blood glucose level |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
252.0 days
| 14 |
|
473.4 |
mg/dl |
10.1 |
37.8 |
|
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
|
|
104086 |
2907 |
GK |
blood glucose level |
running (3.91 km/d) (for 42 days) then fasting (for 12 hours) |
Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015. |
blood glucose amount |
male |
0.0 days
| 20 |
|
165.06 |
mg/dl |
3.78 |
16.9 |
|
oral glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
109902 |
3160 |
GK |
blood glucose level |
resting (for 42 days) then fasting (for 12 hours) then glucose (1 g/kg) (for 2 hours) |
Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015. |
blood glucose amount |
male |
0.0 days
| 20 |
|
352.98 |
mg/dl |
13.68 |
61.18 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
120 |
min |
|
|
|
|
109905 |
3160 |
GK |
blood glucose level |
running (3.91 km/d) (for 42 days) then fasting (for 12 hours) then glucose (1 g/kg) (for 2 hours) |
Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015. |
blood glucose amount |
male |
0.0 days
| 20 |
|
262.44 |
mg/dl |
15.84 |
70.84 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
120 |
min |
|
|
|
|
109906 |
3160 |
WKY/NMolTac |
blood glucose level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood glucose amount |
female |
240.0 days
| 9 |
|
88.2 |
mg/dl |
5.4 |
16.2 |
|
blood glucose test strip read by optical glucometer |
|
0.0 |
|
0 |
|
|
|
|
fasting blood glucose, non fasting blood glucose |
106909 |
3071 |
GK/Jpe |
blood glucose level |
controlled cholesterol content diet (1.25 %) (for 90 days) and controlled cocoa butter content diet (7.5 %) (for 90 days) then fasting (between 15 and 0.2 hours) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
blood glucose amount |
male |
540.0 days
| 10 |
|
151.7 |
mg/dl |
7.9 |
24.98 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
108006 |
3108 |
W/Jpe |
blood glucose level |
fasting (for 15 hours) then glucose solution (1.75 g/kg) (for 2 hours) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
blood glucose amount |
male |
540.0 days
| 20 |
|
116.3 |
mg/dl |
4.0 |
17.89 |
|
intraperitoneal glucose tolerance test |
|
0.0 |
|
120 |
min |
|
|
|
|
108009 |
3108 |
GK/Jpe |
blood glucose level |
controlled cholesterol content diet (1.25 %) (for 90 days) and controlled cocoa butter content diet (7.5 %) (for 90 days) then lipoic acid (50 mg/kg) then fasting (for 15 hours) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
blood glucose amount |
male |
540.0 days
| 10 |
|
122.3 |
mg/dl |
9.3 |
29.41 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
108008 |
3108 |
GK/Jpe |
blood glucose level |
controlled cholesterol content diet (1.25 %) (for 90 days) and controlled cocoa butter content diet (7.5 g/kg) (for 90 days) then soybean oil (2 ml/kg) then fasting (2 ml/kg) (for 15 hours) then glucose solution (1.75 g/kg) (for 2 hours) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
blood glucose amount |
male |
540.0 days
| 10 |
|
338.6 |
mg/dl |
23.4 |
74.0 |
|
intraperitoneal glucose tolerance test |
|
0.0 |
|
120 |
min |
|
|
|
|
108012 |
3108 |
GK/Jpe |
blood glucose level |
controlled cholesterol content diet (1.25 %) (for 90 days) and controlled cocoa butter content diet (7.5 %) (for 90 days) then lipoic acid (50 mg/kg) then fasting (for 15 hours) then glucose solution (1.75 g/kg) (for 2 hours) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
blood glucose amount |
male |
540.0 days
| 10 |
|
365.6 |
mg/dl |
9.5 |
30.04 |
|
intraperitoneal glucose tolerance test |
|
0.0 |
|
120 |
min |
|
|
|
|
108013 |
3108 |
GK/MolTac |
blood glucose level |
fasting (for 6 hours) |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood glucose amount |
female |
420.0 days
| 11 |
|
228.6 |
mg/dl |
9.0 |
29.85 |
|
blood glucose test strip read by optical glucometer |
|
0.0 |
|
0 |
|
|
|
|
fasting blood glucose, non fasting blood glucose |
106913 |
3071 |
WKY/NMolTac |
blood glucose level |
fasting (for 6 hours) |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood glucose amount |
female |
420.0 days
| 9 |
|
138.6 |
mg/dl |
5.4 |
16.2 |
|
blood glucose test strip read by optical glucometer |
|
0.0 |
|
0 |
|
|
|
|
fasting blood glucose, non fasting blood glucose |
106916 |
3071 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) then glucose |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
105.0 days
| 10 |
|
124.2 |
mg/dl |
7.2 |
22.77 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
0 |
min |
|
|
|
|
110745 |
3183 |
GK/MolTac |
blood glucose level |
control condition |
Kold-Petersen H, etal., J Vasc Res. 2012;49(3):267-78. doi: 10.1159/000335487. Epub 2012 Apr 11. |
blood glucose amount |
male |
154.0 days
| 0 |
|
165.6 |
mg/dl |
34.2 |
|
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
108037 |
3109 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) then glucose (for 0.5 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
105.0 days
| 9 |
|
289.8 |
mg/dl |
12.6 |
37.8 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
30 |
min |
|
|
|
|
110749 |
3183 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) then glucose (for 1.5 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
105.0 days
| 8 |
|
253.8 |
mg/dl |
16.2 |
45.82 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
90 |
min |
|
|
|
|
110753 |
3183 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) then glucose (for 2 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
105.0 days
| 8 |
|
217.8 |
mg/dl |
10.8 |
30.55 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
120 |
min |
|
|
|
|
110756 |
3183 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
112.0 days
| 10 |
median |
126.0 |
mg/dl |
|
|
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
7.3; 6.2 75%; 25% |
|
|
110739 |
3183 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
119.0 days
| 9 |
median |
113.4 |
mg/dl |
|
|
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
7.9; 5.9 75%; 25% |
|
|
110743 |
3183 |
HanTac:WH |
blood glucose level |
anti-rh-VEGF165 monoclonal antibody (1 mg) (for 42 days) |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
98.0 days
| 8 |
|
113.4 |
mg/dl |
3.6 |
10.18 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
110274 |
3168 |
HanTac:WH |
blood glucose level |
anti-rh-VEGF165 monoclonal antibody (1 mg) (for 14 days) |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
70.0 days
| 8 |
|
111.6 |
mg/dl |
3.6 |
10.18 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
110266 |
3168 |
GK/Jpe |
blood glucose level |
fasting (for 15 hours) |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
blood glucose amount |
male |
540.0 days
| 7 |
|
115.02 |
mg/dl |
7.2 |
19.05 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
110846 |
3193 |
GK/Jpe |
blood glucose level |
fasting (for 15 hours) then glucose solution (1.75 g/kg) (for 2 hours) |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
blood glucose amount |
male |
540.0 days
| 7 |
|
332.1 |
mg/dl |
48.6 |
128.58 |
|
intraperitoneal glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
110866 |
3193 |
GK/Jpe |
blood glucose level |
controlled cocoa butter content diet (7.5 %) (for 90 days) and controlled cholesterol content diet (1.25 %) (for 90 days) then fasting (for 15 hours) then glucose solution (1.75 g/kg) (for 2 hours) |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
blood glucose amount |
male |
540.0 days
| 7 |
|
418.68 |
mg/dl |
28.8 |
76.2 |
|
intraperitoneal glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
110867 |
3193 |
F344/StmMcwi |
blood glucose level |
controlled ethanol content drinking water used as vehicle (0.1 %) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
male |
91.0 days
| 11 |
|
94.36 |
mg/dl |
2.63 |
8.73 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139541 |
3292 |
M520/NRrrcMcwi |
blood glucose level |
controlled bisphenol F content drinking water (1.125 mg/l) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
male |
91.0 days
| 10 |
|
78.3 |
mg/dl |
2.5 |
7.9 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139865 |
3292 |
WKY/NCrl |
blood glucose level |
controlled ethanol content drinking water used as vehicle (0.1 %) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
female |
91.0 days
| 10 |
|
69.8 |
mg/dl |
1.55 |
4.92 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139928 |
3292 |
N:HS |
blood glucose level |
glucose solution (2 g/kg) |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood glucose amount |
both |
118.0 days-125.0 days |
220 |
|
111.6 |
mg/dl |
0.49 |
7.2 |
|
intraperitoneal glucose tolerance test |
|
0 |
glucose injection |
0 |
min |
|
|
|
|
65944 |
114 |
F344/DuCrlCrlj |
blood glucose level |
partial pancreatectomy (70 %) |
Ogino GenetRes 73:29 '99 |
blood glucose amount |
male |
70.0 days
| 9 |
|
117.8 |
mg/dl |
2.7 |
8.1 |
|
blood glucose test strip read by electrochemical glucometer |
tail |
0.0 |
post pancreatectomy |
28 |
days |
Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan |
converted from mg/dl |
|
|
11416 |
84 |
F344/DuCrlCrlj |
blood glucose level |
partial pancreatectomy (70 %) |
Ogino GenetRes 73:29 '99 |
blood glucose amount |
male |
56.0 days
| 9 |
|
120.1 |
mg/dl |
5.9 |
17.7 |
|
blood glucose test strip read by electrochemical glucometer |
tail |
0.0 |
post pancreatectomy |
14 |
days |
Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan |
converted from mg/dl |
|
|
11418 |
84 |
OLETF/Got |
blood glucose level |
partial pancreatectomy (70 %) |
Ogino GenetRes 73:29 '99 |
blood glucose amount |
male |
63.0 days
| 13 |
|
247.1 |
mg/dl |
22.6 |
81.49 |
|
blood glucose test strip read by electrochemical glucometer |
tail |
0.0 |
post pancreatectomy |
21 |
days |
Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan |
converted from mg/dl |
|
|
11424 |
84 |
F344/DuCrlCrlj |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 15 |
|
135.0 |
mg/dl |
5.4 |
20.91 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
60 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11434 |
85 |
F344/DuCrlCrlj |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 15 |
|
219.6 |
mg/dl |
5.4 |
20.91 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
30 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11437 |
85 |
F344/DuCrlCrlj |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65.0 days
| 15 |
|
88.2 |
mg/dl |
3.6 |
13.94 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
60 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11454 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65.0 days
| 11 |
|
88.2 |
mg/dl |
1.8 |
5.97 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
60 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11455 |
85 |
F344/DuCrlCrlj |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65.0 days
| 15 |
|
169.2 |
mg/dl |
5.4 |
20.91 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
30 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11458 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65.0 days
| 11 |
|
311.4 |
mg/dl |
10.8 |
35.82 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
15 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11463 |
85 |
GK/KyoSwe |
blood glucose level |
fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) |
Galli J, et al., NatGenet 1996 Jan;12(1):31-7. |
blood glucose amount |
not specified |
65.0 days
| 22 |
|
352.8 |
mg/dl |
14.4 |
67.54 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
glucose injection |
30 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11385 |
82 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 11 |
|
153.0 |
mg/dl |
5.4 |
17.91 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
60 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11436 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (for 6 hours) then glucose solution (2 g/kg) |
Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. |
blood glucose amount |
male |
95.0 days
| 12 |
|
297.0 |
mg/dl |
12.6 |
43.65 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
30 |
min |
|
|
|
|
13092 |
330 |
F344.GK-(D1Mgh14-D1Rat90)/Swe |
blood glucose level |
fasting (for 6 hours) then glucose solution (2 g/kg) |
Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. |
blood glucose amount |
male |
95.0 days
| 12 |
|
250.2 |
mg/dl |
10.8 |
37.41 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
30 |
min |
|
|
|
|
13107 |
330 |
F344.GK-(D1Rat83-D1Rat376)/Swe |
blood glucose level |
fasting (for 6 hours) then glucose solution (2 g/kg) |
Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. |
blood glucose amount |
male |
95.0 days
| 12 |
|
333.0 |
mg/dl |
7.2 |
24.94 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
15 |
min |
|
|
|
|
13110 |
330 |
F344/NSlc |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 22 |
|
87.0 |
mg/dl |
1.2 |
5.63 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
0 |
min |
Arkray, Kyoto, Japan |
|
|
|
13206 |
230 |
F344/NSlc |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 22 |
|
105.6 |
mg/dl |
1.5 |
7.04 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
30 |
min |
Arkray, Kyoto, Japan |
|
|
|
13207 |
230 |
F344.OLETF-(D8Rat54-D8Mgh17)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 19 |
|
120.7 |
mg/dl |
2.5 |
10.9 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
30 |
min |
Arkray, Kyoto, Japan |
|
|
|
13222 |
230 |
F344.OLETF-(D8Rat54-D8Mgh17)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 19 |
|
118.8 |
mg/dl |
2.4 |
10.46 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
90 |
min |
Arkray, Kyoto, Japan |
|
|
|
13224 |
230 |
BN/CrlCrlj |
blood glucose level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood glucose amount |
male |
120.0 days
| 5 |
|
154.7 |
mg/dl |
13.8 |
30.86 |
|
oral glucose tolerance test |
|
|
glucose challenge |
120 |
min |
glucose dose not specified |
serum glucose |
|
WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus |
12910 |
321 |
F344/NSlc |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420.0 days
| 7 |
|
149.1 |
mg/dl |
4.2 |
11.11 |
|
oral glucose tolerance test |
|
0 |
oral dose |
30 |
min |
|
|
|
|
13158 |
106 |
SDT/Jcl |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420.0 days
| 5 |
|
566.2 |
mg/dl |
26.69 |
59.68 |
|
oral glucose tolerance test |
|
0 |
oral dose |
0 |
min |
|
|
|
|
13162 |
106 |
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj |
blood glucose level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood glucose amount |
male |
211.0 days
| 7 |
|
78.7 |
mg/dl |
3.4 |
9.0 |
|
oral glucose tolerance test |
|
0 |
oral glucose |
0 |
min |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
|
|
|
12786 |
311 |
F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 13 |
|
118.5 |
mg/dl |
3.5 |
12.62 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
30 |
min |
Arkray, Kyoto, Japan |
|
|
|
13227 |
230 |
F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 13 |
|
119.8 |
mg/dl |
3.4 |
12.26 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
90 |
min |
Arkray, Kyoto, Japan |
|
|
|
13229 |
230 |
F344.OLETF-(D5Mgh4-D5Rat21)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 10 |
|
115.2 |
mg/dl |
3.4 |
10.75 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
120 |
min |
Arkray, Kyoto, Japan |
|
|
|
13245 |
230 |
F344.OLETF-(D9Mgh8-D9Mit2)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 8 |
|
101.1 |
mg/dl |
3.4 |
9.62 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
90 |
min |
Arkray, Kyoto, Japan |
|
|
|
13249 |
230 |
F344.OLETF-(D9Mgh8-D9Mit2)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 8 |
|
99.6 |
mg/dl |
3.2 |
9.05 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
60 |
min |
Arkray, Kyoto, Japan |
|
|
|
13248 |
230 |
F344.OLETF-(D12Wox5-D12Rat21)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 13 |
|
103.0 |
mg/dl |
2.6 |
9.37 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
60 |
min |
Arkray, Kyoto, Japan |
|
|
|
13253 |
230 |
F344.OLETF-(D9Mgh8-D9Mit2)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 8 |
|
103.5 |
mg/dl |
3.0 |
8.49 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
120 |
min |
Arkray, Kyoto, Japan |
|
|
|
13250 |
230 |
F344.OLETF-(D12Wox5-D12Rat21)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 13 |
|
102.2 |
mg/dl |
1.8 |
6.49 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
90 |
min |
Arkray, Kyoto, Japan |
|
|
|
13254 |
230 |
F344.OLETF-(D14Rat8-D14Rat26)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 14 |
|
91.4 |
mg/dl |
1.1 |
4.12 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
0 |
min |
Arkray, Kyoto, Japan |
|
|
|
13256 |
230 |
F344.OLETF-(D12Wox5-D12Rat21)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 13 |
|
103.5 |
mg/dl |
2.3 |
8.29 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
120 |
min |
Arkray, Kyoto, Japan |
|
|
|
13255 |
230 |
F344.OLETF-(D10Wox7-D10Wox6)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 7 |
|
96.7 |
mg/dl |
1.2 |
3.17 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
90 |
min |
Arkray, Kyoto, Japan |
|
|
|
13269 |
230 |
F344/DuCrlCrlj |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 20 |
|
248.4 |
mg/dl |
|
|
|
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
30 |
min |
|
|
|
|
67649 |
85 |
F344/DuCrlCrlj |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 20 |
|
118.8 |
mg/dl |
|
|
|
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
60 |
min |
|
|
|
|
67650 |
85 |
BN/SsN |
blood glucose level |
glucose solution (2 g/kg) |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood glucose amount |
both |
118.0 days-125.0 days |
220 |
|
116.64 |
mg/dl |
1.5 |
22.32 |
|
intraperitoneal glucose tolerance test |
|
0 |
glucose injection |
120 |
min |
|
|
|
|
65981 |
114 |
Crl:SD |
blood glucose level |
controlled fructose content drinking water (5 %) (for 63 days) and controlled bisphenol A content drinking water (0.25 mg/l) (for 63 days) |
Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8. |
blood glucose amount |
female |
98.0 days
| 12 |
|
79.2 |
mg/dl |
1.87 |
6.48 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
week one |
|
|
75794 |
1538 |
WOKW/K |
blood glucose level |
control condition |
Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. |
blood glucose amount |
not specified |
196.0 days-224.0 days |
12 |
|
94.0 |
mg/dl |
1.73 |
6.0 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
|
|
|
|
96848 |
1123 |
DA/K |
blood glucose level |
control condition |
Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. |
blood glucose amount |
not specified |
196.0 days-224.0 days |
12 |
|
105.0 |
mg/dl |
2.31 |
8.0 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
|
|
|
|
96849 |
1123 |
Crl:SD |
blood glucose level |
controlled ethanol content drinking water (1 %) (for 63 days) |
Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8. |
blood glucose amount |
female |
98.0 days
| 12 |
|
82.8 |
mg/dl |
4.1 |
14.22 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
week one |
|
|
75791 |
1538 |
Crl:SD |
blood glucose level |
controlled fructose content drinking water (5 %) (for 63 days) and controlled bisphenol A content drinking water (2.5 mg/l) (for 63 days) |
Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8. |
blood glucose amount |
female |
98.0 days
| 12 |
|
81.0 |
mg/dl |
2.75 |
9.54 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
week one |
|
|
75795 |
1538 |
SD |
blood glucose level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
female |
85.0 days-99.0 days |
6 |
|
82.67 |
mg/dl |
9.41 |
23.04 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
Siemens biochemical analyzer |
|
|
|
84997 |
1602 |
OLETF |
blood glucose level |
olmesartan medoxomil (0.35 mg/kg/d) (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
blood glucose amount |
male |
364.0 days
| 11 |
|
189.54 |
mg/dl |
9.72 |
32.24 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
99417 |
2298 |
OLETF |
blood glucose level |
temocapril (3.9 mg/kg/d) (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
blood glucose amount |
male |
364.0 days
| 11 |
|
182.88 |
mg/dl |
7.38 |
24.48 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
99419 |
2298 |
LH/Mav |
blood glucose level |
streptozotocin (75 mg/kg) then fasting (for 16 hours) then glucose (2 g/kg) (for 1 hours) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood glucose amount |
male |
56.0 days
| 14 |
|
358.0 |
mg/dl |
11.0 |
41.16 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
102721 |
2721 |
LL/Mav |
blood glucose level |
streptozotocin (100 mg/kg) then fasting (for 16 hours) then glucose (2 g/kg) (for 1 hours) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood glucose amount |
male |
56.0 days
| 18 |
|
337.0 |
mg/dl |
10.0 |
42.43 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
102719 |
2721 |
GK |
blood glucose level |
fasting (for 16 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
blood glucose amount |
male |
134.0 days
| 6 |
|
163.0 |
mg/dl |
13.0 |
31.84 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103509 |
2827 |
WKY/NCrl |
blood glucose level |
fasting (for 16 hours) then glucose (2 g/kg) (for 2 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
blood glucose amount |
male |
134.0 days
| 6 |
|
124.0 |
mg/dl |
3.0 |
7.35 |
|
oral glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
103514 |
2827 |
GK |
blood glucose level |
salidroside (40 mg/kg) (for 28 days) then fasting (for 16 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
blood glucose amount |
male |
168.0 days
| 6 |
|
141.0 |
mg/dl |
15.0 |
36.74 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103513 |
2827 |
WKY/NCrl |
blood glucose level |
fasting (for 16 hours) then glucose (2 g/kg) (for 2 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
blood glucose amount |
male |
134.0 days
| 6 |
|
118.0 |
mg/dl |
4.0 |
9.8 |
|
oral glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
103515 |
2827 |
GK |
blood glucose level |
vehicle control condition (for 28 days) then fasting (for 16 hours) then glucose (2 g/kg) (for 2 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
blood glucose amount |
male |
168.0 days
| 6 |
|
278.0 |
mg/dl |
20.0 |
48.99 |
|
oral glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
103520 |
2827 |
GK |
blood glucose level |
salidroside (40 mg/kg) (for 28 days) then fasting (for 16 hours) then glucose (2 g/kg) (for 2 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
blood glucose amount |
male |
168.0 days
| 6 |
|
297.0 |
mg/dl |
25.0 |
61.24 |
|
oral glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
103521 |
2827 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0.0 days
| 16 |
|
308.0 |
mg/dl |
15.0 |
60.0 |
|
machine read blood glucose test strip |
|
0.0 |
unx |
168 |
days |
|
|
|
|
99973 |
2378 |
Crlj:WI |
blood glucose level |
controlled air oxygen content (21 %) (for 28 days) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
blood glucose amount |
male |
16.0 days
| 6 |
|
127.8 |
mg/dl |
7.2 |
17.64 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
103003 |
2784 |
LL/Mav |
blood glucose level |
vehicle control condition then fasting (for 16 hours) then glucose (2 g/kg) (for 1 hours) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood glucose amount |
male |
49.0 days-56.0 days |
13 |
|
132.0 |
mg/dl |
4.0 |
14.42 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
102659 |
2703 |
LH/Mav |
blood glucose level |
vehicle control condition then fasting (for 16 hours) then glucose (2 g/kg) (for 1 hours) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood glucose amount |
male |
49.0 days-56.0 days |
8 |
|
121.0 |
mg/dl |
6.0 |
16.97 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
102660 |
2703 |
LL/Mav |
blood glucose level |
vehicle control condition then fasting (for 16 hours) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood glucose amount |
male |
56.0 days
| 9 |
|
70.0 |
mg/dl |
1.0 |
3.0 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
102714 |
2721 |
Jcl:WI |
blood glucose level |
control condition then fasting (for 12 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
24.0 days
| 6 |
|
80.85 |
mg/dl |
1.42 |
3.48 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103912 |
2884 |
GK/Jcl |
blood glucose level |
control condition then fasting (for 0 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
24.0 days
| 6 |
|
109.71 |
mg/dl |
2.38 |
5.83 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103913 |
2884 |
GK/Jcl |
blood glucose level |
controlled hesperidin content diet (1 %) then fasting (for 0 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
24.0 days
| 6 |
|
111.5 |
mg/dl |
3.29 |
8.06 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103914 |
2884 |
GK/Jcl |
blood glucose level |
controlled hesperidin content diet (1 %) (for 7 days) then fasting (for 0 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
31.0 days
| 6 |
|
118.28 |
mg/dl |
4.58 |
11.22 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103918 |
2884 |
GK/Jcl |
blood glucose level |
controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 14 days) then fasting (for 12 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
38.0 days
| 6 |
|
98.57 |
mg/dl |
1.61 |
3.94 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103923 |
2884 |
Jcl:WI |
blood glucose level |
control condition then fasting (for 0 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
45.0 days
| 6 |
|
96.85 |
mg/dl |
3.52 |
8.62 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103924 |
2884 |
GK/MolTac |
blood glucose level |
control condition |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood glucose amount |
male |
144.0 days
| 6 |
|
382.0 |
mg/dl |
69.0 |
169.01 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
103990 |
2885 |
SDT/Jcl |
blood glucose level |
nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled content diet (1 %) (for 70 days) and paricalcitol (0.1 ug/kg) (for 70 days) |
Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170. |
blood glucose amount |
male |
140.0 days
| 7 |
|
143.1 |
mg/dl |
5.5 |
14.55 |
|
blood glucose analysis |
|
0.0 |
unx |
84 |
days |
|
|
|
|
100121 |
2419 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0.0 days
| 8 |
|
352.0 |
mg/dl |
17.0 |
48.08 |
|
machine read blood glucose test strip |
|
0.0 |
unx |
28 |
days |
|
|
|
|
99942 |
2378 |
SD-Lepem1Sage+/+ |
blood glucose level |
fasting (for 16 hours) then standard diet (for 1 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood glucose amount |
female |
91.0 days
| 6 |
|
142.56 |
mg/dl |
12.42 |
30.42 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
104472 |
2949 |
SD-Fhem1+/- |
blood glucose level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood glucose amount |
male |
0.0 days
| 3 |
|
129.6 |
mg/dl |
4.16 |
7.2 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
|
|
|
|
104967 |
2989 |
MNS |
blood glucose level |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
84.0 days
| 9 |
|
113.4 |
mg/dl |
4.8 |
14.4 |
|
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
|
|
104074 |
2907 |
MHS |
blood glucose level |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
252.0 days
| 14 |
|
113.4 |
mg/dl |
2.89 |
10.8 |
|
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
|
|
104083 |
2907 |
MNS |
blood glucose level |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
252.0 days
| 11 |
|
473.4 |
mg/dl |
13.03 |
43.2 |
|
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
|
|
104082 |
2907 |
MHS |
blood glucose level |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 84 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
168.0 days
| 9 |
|
462.6 |
mg/dl |
19.8 |
59.4 |
|
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
|
|
104080 |
2907 |
GK |
blood glucose level |
resting (for 42 days) then fasting (for 12 hours) then glucose (1 g/kg) (for 1 hours) |
Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015. |
blood glucose amount |
male |
0.0 days
| 20 |
|
369.18 |
mg/dl |
10.44 |
46.69 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
60 |
min |
|
|
|
|
109903 |
3160 |
GK/CskCrlj |
blood glucose level |
fasting (for 17 hours) |
Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412. |
blood glucose amount |
male |
224.0 days-238.0 days |
10 |
|
197.4 |
mg/dl |
4.8 |
15.18 |
|
automated plasma glucose analysis |
|
0.0 |
|
0 |
|
200ul blood taken from tail vein |
|
|
|
106891 |
3070 |
GK/MolTac |
blood glucose level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood glucose amount |
female |
240.0 days
| 11 |
|
311.4 |
mg/dl |
14.4 |
47.76 |
|
blood glucose test strip read by optical glucometer |
|
0.0 |
|
0 |
|
|
|
|
fasting blood glucose, non fasting blood glucose |
106906 |
3071 |
Crlj:WI |
blood glucose level |
control condition |
Wakuta M, etal., Invest Ophthalmol Vis Sci. 2007 Feb;48(2):590-6. doi: 10.1167/iovs.05-1168. |
blood glucose amount |
male |
91.0 days-105.0 days |
5 |
|
116.0 |
mg/dl |
4.92 |
11.0 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
107994 |
3106 |
GK/Jpe |
blood glucose level |
control condition then fasting (for 15 hours) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
blood glucose amount |
male |
540.0 days
| 20 |
|
115.3 |
mg/dl |
5.6 |
25.04 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
108005 |
3108 |
W/Jpe |
blood glucose level |
fasting (for 15 hours) |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
blood glucose amount |
male |
540.0 days
| 7 |
|
73.26 |
mg/dl |
1.8 |
4.76 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
110860 |
3193 |
W/Kyo |
blood glucose level |
control condition |
Kondo H, etal., Muscle Nerve. 2015 Mar;51(3):391-9. doi: 10.1002/mus.24316. Epub 2015 Jan 6. |
blood glucose amount |
male |
63.0 days
| 6 |
|
118.8 |
mg/dl |
7.2 |
17.64 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
108042 |
3110 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) then glucose (for 1 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
105.0 days
| 10 |
|
307.8 |
mg/dl |
19.8 |
62.61 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
60 |
min |
|
|
|
|
110751 |
3183 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) then glucose (for 1.5 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
105.0 days
| 10 |
|
279.0 |
mg/dl |
14.4 |
45.54 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
90 |
min |
|
|
|
|
110754 |
3183 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) then glucose (for 2 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
105.0 days
| 9 |
|
219.6 |
mg/dl |
7.2 |
21.6 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
120 |
min |
|
|
|
|
110758 |
3183 |
HanTac:WH |
blood glucose level |
control IgG monoclonal antibody (1 mg) (for 42 days) |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
98.0 days
| 8 |
|
99.0 |
mg/dl |
10.8 |
30.55 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
110273 |
3168 |
HanTac:WH |
blood glucose level |
control condition |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
56.0 days
| 8 |
|
109.8 |
mg/dl |
1.8 |
5.09 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
110262 |
3168 |
GK/MolTac |
blood glucose level |
control IgG monoclonal antibody (1 mg) (for 28 days) |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
84.0 days
| 9 |
|
127.8 |
mg/dl |
1.8 |
5.4 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
110271 |
3168 |
GK/MolTac |
blood glucose level |
control IgG monoclonal antibody (1 mg) (for 14 days) |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
70.0 days
| 9 |
|
117.0 |
mg/dl |
1.8 |
5.4 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
110267 |
3168 |
HanTac:WH |
blood glucose level |
control IgG monoclonal antibody (1 mg) (for 28 days) |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
84.0 days
| 8 |
|
102.6 |
mg/dl |
1.8 |
5.09 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
110269 |
3168 |
GK/MolTac |
blood glucose level |
anti-rh-VEGF165 monoclonal antibody (1 mg) (for 28 days) |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
84.0 days
| 10 |
|
129.6 |
mg/dl |
1.8 |
5.69 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
110272 |
3168 |
GK/Jpe |
blood glucose level |
controlled cocoa butter content diet (7.5 %) (for 90 days) and controlled cholesterol content diet (1.25 %) (for 90 days) and soybean oil (2 ml/kg) (for 90 days) then fasting (for 15 hours) then glucose solution (1.75 g/kg) (for 2 hours) |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
blood glucose amount |
male |
540.0 days
| 7 |
|
358.2 |
mg/dl |
14.4 |
38.1 |
|
intraperitoneal glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
110868 |
3193 |
BN/NHsdMcwi |
blood glucose level |
controlled bisphenol F content drinking water (1.125 mg/l) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
female |
91.0 days
| 10 |
|
75.7 |
mg/dl |
3.05 |
9.65 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138967 |
3292 |
BN/NHsdMcwi |
blood glucose level |
controlled ethanol content drinking water used as vehicle (0.1 %) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
male |
91.0 days
| 10 |
|
74.9 |
mg/dl |
1.78 |
5.63 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien , animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139029 |
3292 |
BUF/MnaMcwi |
blood glucose level |
controlled ethanol content drinking water used as vehicle (0.1 %) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
female |
91.0 days
| 10 |
|
84.5 |
mg/dl |
2.86 |
9.03 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139154 |
3292 |
BUF/MnaMcwi |
blood glucose level |
controlled bisphenol F content drinking water (1.125 mg/l) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
female |
91.0 days
| 7 |
|
83.86 |
mg/dl |
4.26 |
11.28 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139220 |
3292 |
WKY/NCrl |
blood glucose level |
controlled bisphenol F content drinking water (1.125 mg/l) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
female |
91.0 days
| 10 |
|
73.0 |
mg/dl |
2.44 |
7.7 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139994 |
3292 |
ACI/EurMcwi |
blood glucose level |
controlled ethanol content drinking water used as vehicle (0.1 %) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
male |
91.0 days
| 11 |
|
71.45 |
mg/dl |
1.36 |
4.52 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien, animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
138789 |
3292 |
BUF/N |
blood glucose level |
glucose solution (2 g/kg) |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood glucose amount |
both |
118.0 days-125.0 days |
220 |
|
166.14 |
mg/dl |
|
|
|
intraperitoneal glucose tolerance test |
|
0 |
glucose injection |
0 |
min |
|
|
|
|
65947 |
114 |
F344/DuCrl |
blood glucose level |
fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) |
Galli J, et al., NatGenet 1996 Jan;12(1):31-7. |
blood glucose amount |
not specified |
65.0 days
| 10 |
|
147.6 |
mg/dl |
10.8 |
34.15 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
glucose injection |
30 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11394 |
82 |
OLETF/Got |
blood glucose level |
partial pancreatectomy (70 %) |
Ogino GenetRes 73:29 '99 |
blood glucose amount |
male |
49.0 days
| 13 |
|
264.9 |
mg/dl |
22.9 |
82.57 |
|
blood glucose test strip read by electrochemical glucometer |
tail |
0.0 |
post pancreatectomy |
7 |
days |
Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan |
converted from mg/dl |
|
|
11422 |
84 |
OLETF/Got |
blood glucose level |
partial pancreatectomy (70 %) |
Ogino GenetRes 73:29 '99 |
blood glucose amount |
male |
45.0 days
| 13 |
|
140.5 |
mg/dl |
11.5 |
41.46 |
|
blood glucose test strip read by electrochemical glucometer |
tail |
0.0 |
post pancreatectomy |
3 |
days |
Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan |
converted from mg/dl |
|
|
11421 |
84 |
F344/DuCrlCrlj |
blood glucose level |
partial pancreatectomy (70 %) |
Ogino GenetRes 73:29 '99 |
blood glucose amount |
male |
45.0 days
| 9 |
|
115.8 |
mg/dl |
3.4 |
10.2 |
|
blood glucose test strip read by electrochemical glucometer |
tail |
0.0 |
post pancreatectomy |
3 |
days |
Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan |
converted from mg/dl |
|
|
11427 |
84 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65.0 days
| 11 |
|
86.4 |
mg/dl |
3.6 |
11.94 |
|
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11453 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65.0 days
| 11 |
|
99.0 |
mg/dl |
3.6 |
11.94 |
|
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
60 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11457 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65.0 days
| 11 |
|
189.0 |
mg/dl |
7.2 |
23.88 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
30 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11459 |
85 |
F344/DuCrlCrlj |
blood glucose level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
185.0 days
| 9 |
|
102.6 |
mg/dl |
1.8 |
5.4 |
|
blood glucose analysis |
tail vein |
|
|
0 |
|
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11479 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 11 |
|
145.8 |
mg/dl |
9.0 |
29.85 |
|
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
60 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11435 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 11 |
|
129.6 |
mg/dl |
3.6 |
11.94 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11433 |
85 |
GK/KyoSwe |
blood glucose level |
fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) |
Galli J, et al., NatGenet 1996 Jan;12(1):31-7. |
blood glucose amount |
not specified |
65.0 days
| 22 |
|
298.8 |
mg/dl |
12.6 |
59.1 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
glucose injection |
120 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11387 |
82 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 11 |
|
253.8 |
mg/dl |
12.6 |
41.79 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
30 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
|
|
11439 |
85 |
F344/NCrl |
blood glucose level |
fasting (for 6 hours) then glucose solution (2 g/kg) |
Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. |
blood glucose amount |
male |
95.0 days
| 12 |
|
246.6 |
mg/dl |
9.0 |
31.18 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
30 |
min |
|
|
|
|
13087 |
330 |
F344/NCrl |
blood glucose level |
fasting (for 6 hours) then glucose solution (2 g/kg) |
Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. |
blood glucose amount |
male |
95.0 days
| 12 |
|
325.8 |
mg/dl |
10.8 |
37.41 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
15 |
min |
|
|
|
|
13086 |
330 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (for 6 hours) then glucose solution (2 g/kg) |
Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. |
blood glucose amount |
male |
95.0 days
| 12 |
|
367.2 |
mg/dl |
9.0 |
31.18 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
15 |
min |
|
|
|
|
13091 |
330 |
F344.GK-(D1Rat83-D1Rat376)/Swe |
blood glucose level |
fasting (for 6 hours) then glucose solution (2 g/kg) |
Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. |
blood glucose amount |
male |
95.0 days
| 12 |
|
243.0 |
mg/dl |
9.0 |
31.18 |
|
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
30 |
min |
|
|
|
|
13111 |
330 |
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 16 |
|
88.8 |
mg/dl |
1.4 |
5.6 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
0 |
min |
Arkray, Kyoto, Japan |
|
|
|
13211 |
230 |
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 16 |
|
127.1 |
mg/dl |
3.5 |
14.0 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
60 |
min |
Arkray, Kyoto, Japan |
|
|
|
13213 |
230 |
F344.OLETF-(D14Rat8-D14Rat26)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 15 |
|
85.9 |
mg/dl |
1.8 |
6.97 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
0 |
min |
Arkray, Kyoto, Japan |
|
|
|
13216 |
230 |
F344.OLETF-(D8Rat54-D8Mgh17)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 19 |
|
89.5 |
mg/dl |
1.1 |
4.79 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
0 |
min |
Arkray, Kyoto, Japan |
|
|
|
13221 |
230 |
BN/CrlCrlj |
blood glucose level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood glucose amount |
male |
120.0 days
| 5 |
|
211.3 |
mg/dl |
17.9 |
40.03 |
|
oral glucose tolerance test |
|
|
glucose challenge |
60 |
min |
glucose dose not specified |
serum glucose |
|
WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus |
12909 |
321 |
F344/NSlc |
blood glucose level |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420.0 days
| 7 |
|
149.0 |
mg/dl |
3.52 |
9.31 |
|
oral glucose tolerance test |
|
0 |
oral dose |
120 |
min |
|
|
|
|
13160 |
106 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
blood glucose level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood glucose amount |
male |
211.0 days
| 11 |
|
82.5 |
mg/dl |
3.5 |
11.61 |
|
oral glucose tolerance test |
|
0 |
oral glucose |
0 |
min |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
|
|
|
12792 |
311 |
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj |
blood glucose level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood glucose amount |
male |
211.0 days
| 11 |
|
87.7 |
mg/dl |
3.2 |
10.61 |
|
oral glucose tolerance test |
|
0.0 |
oral glucose |
0 |
min |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
|
|
|
12798 |
311 |
F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 13 |
|
119.5 |
mg/dl |
2.1 |
7.57 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
60 |
min |
Arkray, Kyoto, Japan |
|
|
|
13228 |
230 |
F344.OLETF-(D1Mit20-D1Mgh26)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 15 |
|
107.4 |
mg/dl |
2.3 |
8.91 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
90 |
min |
Arkray, Kyoto, Japan |
|
|
|
13234 |
230 |
F344.OLETF-(D1Rat166-D1Rat90)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 12 |
|
111.8 |
mg/dl |
2.6 |
9.01 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
30 |
min |
Arkray, Kyoto, Japan |
|
|
|
13237 |
230 |
F344.OLETF-(D1Rat166-D1Rat90)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 12 |
|
80.0 |
mg/dl |
2.9 |
10.05 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
0 |
min |
Arkray, Kyoto, Japan |
|
|
|
13236 |
230 |
F344.OLETF-(D5Mgh4-D5Rat21)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 10 |
|
90.0 |
mg/dl |
4.2 |
13.28 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
0 |
min |
Arkray, Kyoto, Japan |
|
|
|
13241 |
230 |
F344.OLETF-(D1Rat166-D1Rat90)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 12 |
|
113.0 |
mg/dl |
2.6 |
9.01 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
60 |
min |
Arkray, Kyoto, Japan |
|
|
|
13238 |
230 |
F344.OLETF-(D5Mgh4-D5Rat21)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 10 |
|
118.4 |
mg/dl |
4.0 |
12.65 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
30 |
min |
Arkray, Kyoto, Japan |
|
|
|
13242 |
230 |
F344.OLETF-(D5Mgh4-D5Rat21)/Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 10 |
|
115.2 |
mg/dl |
2.7 |
8.54 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
90 |
min |
Arkray, Kyoto, Japan |
|
|
|
13244 |
230 |
F344.OLETF-(D9Mgh8-D9Mit2)/2Tj |
blood glucose level |
fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. |
blood glucose amount |
male |
210.0 days
| 8 |
|
81.3 |
mg/dl |
2.0 |
5.66 |
|
oral glucose tolerance test |
tail |
|
gastric gavage |
0 |
min |
Arkray, Kyoto, Japan |
|
|
|
13246 |
230 |
F344/DuCrlCrlj |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95.0 days
| 20 |
|
111.6 |
mg/dl |
|
|
|
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
90 |
min |
|
|
|
|
67651 |
85 |
N:HS |
blood glucose level |
glucose solution (2 g/kg) |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood glucose amount |
both |
118.0 days-125.0 days |
220 |
|
151.2 |
mg/dl |
2.31 |
34.2 |
|
intraperitoneal glucose tolerance test |
|
0 |
glucose injection |
30 |
min |
|
|
|
|
65972 |
114 |
BN/SsN |
blood glucose level |
glucose solution (2 g/kg) |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood glucose amount |
both |
118.0 days-125.0 days |
220 |
|
156.42 |
mg/dl |
3.48 |
51.66 |
|
intraperitoneal glucose tolerance test |
|
0 |
glucose injection |
30 |
min |
|
|
|
|
65975 |
114 |
N:HS |
blood glucose level |
glucose solution (2 g/kg) |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood glucose amount |
both |
118.0 days-125.0 days |
220 |
|
124.2 |
mg/dl |
0.97 |
14.4 |
|
intraperitoneal glucose tolerance test |
|
0.0 |
glucose injection |
60 |
min |
|
|
|
|
65978 |
114 |
WKY/N |
blood glucose level |
glucose solution (2 g/kg) |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood glucose amount |
both |
118.0 days-125.0 days |
220 |
|
221.4 |
mg/dl |
3.37 |
50.04 |
|
intraperitoneal glucose tolerance test |
|
0 |
glucose injection |
120 |
min |
|
|
|
|
65982 |
114 |
F344/NRrrc |
blood glucose level |
glucose solution (2 g/kg) |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood glucose amount |
both |
118.0 days-125.0 days |
220 |
|
158.4 |
mg/dl |
1.09 |
16.2 |
|
intraperitoneal glucose tolerance test |
|
0 |
glucose injection |
120 |
min |
|
|
|
|
65983 |
114 |
Crl:SD |
blood glucose level |
controlled fructose content drinking water (5 %) (for 63 days) and controlled ethanol content drinking water (1 %) (for 63 days) |
Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8. |
blood glucose amount |
female |
98.0 days
| 12 |
|
84.6 |
mg/dl |
3.64 |
12.6 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
week one |
|
|
75792 |
1538 |
SD |
blood glucose level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
male |
71.0 days-85.0 days |
6 |
|
103.7 |
mg/dl |
5.52 |
13.52 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
Siemens biochemical analyzer |
|
|
|
84988 |
1602 |
SD |
blood glucose level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
female |
71.0 days-85.0 days |
6 |
|
109.2 |
mg/dl |
11.08 |
27.13 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
Siemens biochemical analyzer |
|
|
|
84994 |
1602 |
SD |
blood glucose level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
female |
71.0 days-85.0 days |
6 |
|
70.7 |
mg/dl |
4.78 |
11.71 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
Siemens biochemical analyzer |
|
|
|
84993 |
1602 |
GK/Jcl |
blood glucose level |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
blood glucose amount |
male |
84.0 days
| 8 |
|
478.26 |
mg/dl |
23.74 |
67.14 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
103073 |
2785 |
GK/Jcl |
blood glucose level |
Omacor (400 mg/kg/d) (for 56 days) |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
blood glucose amount |
male |
84.0 days
| 8 |
|
388.26 |
mg/dl |
27.37 |
77.4 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
103074 |
2785 |
WKY/NCrl |
blood glucose level |
fasting (for 16 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
blood glucose amount |
male |
134.0 days
| 6 |
|
98.0 |
mg/dl |
3.0 |
7.35 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103507 |
2827 |
WKY/NCrl |
blood glucose level |
vehicle control condition (for 28 days) then fasting (for 16 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
blood glucose amount |
male |
168.0 days
| 6 |
|
113.0 |
mg/dl |
4.0 |
9.8 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103510 |
2827 |
WKY/NCrl |
blood glucose level |
salidroside (40 mg/kg) (for 28 days) then fasting (for 16 hours) then glucose (2 g/kg) (for 2 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
blood glucose amount |
male |
168.0 days
| 6 |
|
121.0 |
mg/dl |
2.0 |
4.9 |
|
oral glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
103519 |
2827 |
GK |
blood glucose level |
controlled air oxygen content (21 %) (for 28 days) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
blood glucose amount |
male |
16.0 days
| 5 |
|
196.2 |
mg/dl |
18.0 |
40.25 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
103005 |
2784 |
GK |
blood glucose level |
bilateral ovariectomy (for 24 days) then fasting (for 12 hours) |
Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31. |
blood glucose amount |
female |
87.0 days
| 6 |
|
148.0 |
mg/dl |
12.0 |
29.39 |
|
machine read blood glucose test strip |
|
0.0 |
|
0 |
|
|
|
|
|
103760 |
2782 |
GK/MolTac |
blood glucose level |
sodium chloride solution (for 23 days) then fasting (for 16 hours) then glucose solution (2 g/kg) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood glucose amount |
male |
95.0 days-102.0 days |
4 |
|
168.0 |
mg/dl |
9.0 |
18.0 |
|
oral glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
103805 |
2864 |
GK/MolTac |
blood glucose level |
rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 16 hours) then glucose solution (2 g/kg) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood glucose amount |
male |
122.0 days-129.0 days |
4 |
|
145.0 |
mg/dl |
7.5 |
15.0 |
|
oral glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
103810 |
2864 |
LL/Mav |
blood glucose level |
streptozotocin (100 mg/kg) then fasting (for 16 hours) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood glucose amount |
male |
56.0 days
| 18 |
|
71.0 |
mg/dl |
1.0 |
4.24 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
102715 |
2721 |
GK/Jcl |
blood glucose level |
controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) then fasting (for 12 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
24.0 days
| 6 |
|
108.28 |
mg/dl |
2.44 |
5.98 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103915 |
2884 |
WKY |
blood glucose level |
vehicle control condition (1 null) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
blood glucose amount |
male |
156.0 days
| 10 |
|
160.56 |
mg/dl |
8.64 |
27.32 |
|
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
|
|
99101 |
2219 |
WKY |
blood glucose level |
streptozotocin (60 mg/kg) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
blood glucose amount |
male |
156.0 days
| 10 |
|
520.92 |
mg/dl |
28.8 |
91.07 |
|
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
|
|
99102 |
2219 |
WKY |
blood glucose level |
streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
blood glucose amount |
male |
156.0 days
| 10 |
|
537.12 |
mg/dl |
28.98 |
91.64 |
|
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
|
|
99105 |
2219 |
SD |
blood glucose level |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
blood glucose amount |
male |
0.0 days
| 8 |
|
343.0 |
mg/dl |
18.38 |
52.0 |
|
blood glucose analysis |
|
0.0 |
stz |
154 |
days |
|
|
|
|
99897 |
2358 |
Crl:WI |
blood glucose level |
control condition then controlled saxagliptin content diet (10 mg/kg/d) (for 12 days) |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood glucose amount |
male |
144.0 days
| 6 |
|
153.0 |
mg/dl |
7.0 |
17.15 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
103989 |
2885 |
GK/MolTac |
blood glucose level |
control condition then controlled saxagliptin content diet (10 mg/kg/d) (for 12 days) |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood glucose amount |
male |
144.0 days
| 12 |
|
305.0 |
mg/dl |
18.0 |
62.35 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
103994 |
2885 |
GK/MolTac |
blood glucose level |
running on treadmill (0-10 m/min) (between 0.1 and 0.2 hours) then controlled saxagliptin content diet (10 mg/kg/d) (for 12 days) then running on treadmill (15 m/min) (for 0.5 hours) then running on treadmill (15 m/min) (for 0.8 hours) |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood glucose amount |
male |
144.0 days
| 12 |
|
289.0 |
mg/dl |
29.0 |
100.46 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
103995 |
2885 |
GK/Jcl |
blood glucose level |
controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days) then fasting (for 12 hours) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood glucose amount |
male |
52.0 days
| 6 |
|
101.71 |
mg/dl |
3.08 |
7.54 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
103931 |
2884 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0.0 days
| 8 |
|
357.0 |
mg/dl |
11.0 |
31.11 |
|
machine read blood glucose test strip |
|
0.0 |
unx |
28 |
days |
|
|
|
|
99943 |
2378 |
SD-Fhem1+/- |
blood glucose level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood glucose amount |
female |
0.0 days
| 3 |
|
108.0 |
mg/dl |
12.47 |
21.6 |
|
automated blood analysis |
|
0.0 |
|
0 |
|
|
|
|
|
104968 |
2989 |
MHS |
blood glucose level |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
84.0 days
| 9 |
|
115.2 |
mg/dl |
3.0 |
9.0 |
|
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
|
|
104075 |
2907 |
SBH/Ygl |
blood glucose level |
controlled sodium chloride content diet (0.65 %) (for 98 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
blood glucose amount |
male |
98.0 days
| 7 |
|
113.4 |
mg/dl |
3.6 |
9.52 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
106692 |
3038 |
GK |
blood glucose level |
resting (for 42 days) then fasting (for 12 hours) |
Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015. |
blood glucose amount |
male |
0.0 days
| 20 |
|
122.76 |
mg/dl |
5.4 |
24.15 |
|
oral glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
109901 |
3160 |
WKY/NMolTac |
blood glucose level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood glucose amount |
female |
420.0 days
| 9 |
|
93.6 |
mg/dl |
5.4 |
16.2 |
|
blood glucose test strip read by optical glucometer |
|
0.0 |
|
0 |
|
|
|
|
fasting blood glucose, non fasting blood glucose |
106910 |
3071 |
GK/CskCrljCrl |
blood glucose level |
control condition |
Wakuta M, etal., Invest Ophthalmol Vis Sci. 2007 Feb;48(2):590-6. doi: 10.1167/iovs.05-1168. |
blood glucose amount |
male |
91.0 days-105.0 days |
6 |
|
259.0 |
mg/dl |
22.45 |
55.0 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
107993 |
3106 |
GK/Jpe |
blood glucose level |
fasting (for 15 hours) then glucose solution (1.75 g/kg) (for 2 hours) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
blood glucose amount |
male |
540.0 days
| 20 |
|
332.5 |
mg/dl |
47.7 |
213.32 |
|
intraperitoneal glucose tolerance test |
|
0.0 |
|
120 |
min |
|
|
|
|
108010 |
3108 |
GK/Jpe |
blood glucose level |
controlled cocoa butter content diet (7.5 %) (for 90 days) and controlled cholesterol content diet (1.25 %) (for 90 days) then fasting (for 15 hours) |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
blood glucose amount |
male |
540.0 days
| 7 |
|
151.56 |
mg/dl |
7.2 |
19.05 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
110862 |
3193 |
GK/Jpe |
blood glucose level |
controlled cocoa butter content diet (7.5 %) (for 90 days) and controlled cholesterol content diet (1.25 %) (for 90 days) and soybean oil (2 ml/kg) (for 90 days) then fasting (for 15 hours) |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
blood glucose amount |
male |
540.0 days
| 7 |
|
129.42 |
mg/dl |
5.4 |
14.29 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
|
|
110863 |
3193 |
Slc:ZUC-Leprfa-/- |
blood glucose level |
fasting (for 17 hours) |
Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412. |
blood glucose amount |
male |
84.0 days-105.0 days |
44 |
|
136.8 |
mg/dl |
2.7 |
17.91 |
|
automated plasma glucose analysis |
|
0.0 |
|
0 |
|
|
slc:zuc-leprfa-/- |
|
|
106937 |
3070 |
GK/MolTac |
blood glucose level |
fasting (for 6 hours) |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood glucose amount |
female |
240.0 days
| 11 |
|
172.8 |
mg/dl |
10.8 |
35.82 |
|
blood glucose test strip read by optical glucometer |
|
0.0 |
|
0 |
|
|
|
|
fasting blood glucose, non fasting blood glucose |
106912 |
3071 |
WKY/NMolTac |
blood glucose level |
fasting (for 6 hours) |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood glucose amount |
female |
60.0 days
| 6 |
|
84.6 |
mg/dl |
5.4 |
13.23 |
|
blood glucose test strip read by optical glucometer |
|
0.0 |
|
0 |
|
|
|
|
fasting blood glucose, non fasting blood glucose |
106914 |
3071 |
W/Kyo |
blood glucose level |
running on treadmill (15 m/min) (for 1 hours) |
Kondo H, etal., Muscle Nerve. 2015 Mar;51(3):391-9. doi: 10.1002/mus.24316. Epub 2015 Jan 6. |
blood glucose amount |
male |
63.0 days
| 6 |
|
102.6 |
mg/dl |
1.8 |
4.41 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
108043 |
3110 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
112.0 days
| 8 |
median |
124.2 |
mg/dl |
|
|
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
7.4; 6.2 75%; 25% |
|
|
110738 |
3183 |
GK/MolTac |
blood glucose level |
fasting (between 14 and 18 hours) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
119.0 days
| 10 |
median |
131.4 |
mg/dl |
|
|
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
8.5; 6.1 75%; 25% |
|
|
110742 |
3183 |
GK/MolTac |
blood glucose level |
control condition |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
56.0 days
| 9 |
|
120.6 |
mg/dl |
1.8 |
5.4 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
110263 |
3168 |
GK/MolTac |
blood glucose level |
control condition |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
56.0 days
| 10 |
|
127.8 |
mg/dl |
1.8 |
5.69 |
|
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
|
110264 |
3168 |
GK/Jpe |
blood glucose level |
controlled cocoa butter content diet (7.5 %) (for 90 days) and controlled cholesterol content diet (1.25 %) (for 90 days) and lipoic acid (50 mg/kg) then fasting (for 15 hours) then glucose solution (1.75 g/kg) (for 2 hours) |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
blood glucose amount |
male |
540.0 days
| 7 |
|
363.6 |
mg/dl |
9.0 |
23.81 |
|
intraperitoneal glucose tolerance test |
|
0.0 |
|
0 |
|
|
|
|
|
110869 |
3193 |
BN/NHsdMcwi |
blood glucose level |
controlled ethanol content drinking water used as vehicle (0.1 %) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
female |
91.0 days
| 10 |
|
76.7 |
mg/dl |
3.19 |
10.09 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138910 |
3292 |
BUF/MnaMcwi |
blood glucose level |
controlled bisphenol F content drinking water (1.125 mg/l) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
male |
91.0 days
| 10 |
|
83.8 |
mg/dl |
3.78 |
11.94 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139349 |
3292 |
F344/StmMcwi |
blood glucose level |
controlled ethanol content drinking water used as vehicle (0.1 %) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
female |
91.0 days
| 9 |
|
83.11 |
mg/dl |
2.57 |
7.72 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139412 |
3292 |
F344/StmMcwi |
blood glucose level |
controlled bisphenol F content drinking water (1.125 mg/l) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
female |
91.0 days
| 9 |
|
81.44 |
mg/dl |
3.62 |
10.85 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139478 |
3292 |
WKY/NCrl |
blood glucose level |
controlled ethanol content drinking water used as vehicle (0.1 %) (for 70 days) then fasting (for 16 hours) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
blood glucose amount |
male |
91.0 days
| 12 |
|
72.58 |
mg/dl |
1.27 |
4.4 |
Download Values
|
blood glucose test strip read by electrochemical glucometer |
|
|
|
0 |
|
"overnight fast, saphenous vien "; "animals were fasted overnight (~16 hours), hind left leg shaved, pricked saphenous vein using a lancet, used glucometer to measure blood glucose" |
Fasted blood glucose |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
140057 |
3292 |